Вы находитесь на странице: 1из 376

,

2014

Whole
Rethinking the Science of Nutrition
T. Colin Campbell, Ph.D.
with Howard Jacobson, PhD

BENBELLA BOOKS, INC.


Dallas, Texas

:

,







615.874
36.996
98

BenBella Books c/o PERSEUS BOOKS, Inc.

, .
98 . / ,
; . . ; [. . . ]. . : ,
, 2014. 376 .
ISBN 978-5-00057-160-6
:
, .
, , , , . , . ,
?

615.874
36.996

.


.
-

ISBN 978-5-00057-160-6

T. Colin Campbell, 2013


First published in the United States by BenBella Books
 , , .
, , 2014


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

I.
1.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50

II.
4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
6. . . . . . . . . . . . . . . . . . . . . . . . 101
7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
8. ( 1). . . . . . . . . . . . . . . . . . . . . . . . . 137
9. ( 2). . . . . . . . . . . . . . . . . . . . . . . . . 156
10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
11. . . . . . . . . . . . . . . . . . . . . . . . . 185
12. . . . . . . . . . . . . . . . . . . . . 201

III.
13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
14. : . . . . . . . . . . . . . . . . . . . . . . . . 233
15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 253
16. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 272
17. . . . . . . . . . . . . . . . . . . . . . . . . . 290
18. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308

IV.
19. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 334
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 340
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 342
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 343


. ,
,
.
- : ,
.
,

, . ,
: ,
. . :
, . . , ,
,
, , , .


, .
,
.
,
,
.
,
, . ,
, !
, -,
,
,

,
, .
, , , ,
.

1965 .
,
.
- ! : ,
,
. .

( - ,
1960- , ).
, ,
. ,
.
.

, Aspergillus flavus.
, . ,
: , Aspergillus

13


flavus (
: , , , ).
, Aspergillus flavus
. ,
:
. , ,
(
Aspergillus flavus),
,
.
, ,
: , , ,
.
, .
,
*. . -,
. -, ,
, .
, ,
( ). , ,
,
. ,
*
: ., . .
. .: , , 2013.
..

14


, .
, ,
, , , ,
,
.
, , : .
. , ,
.

, .
, , .
.
.
,
.

, ,

.
? , ,
.

?
, .

15


, ,
.

2005 ,
, , , .
. , . ,
, .
2005 ,
. , ,
,
,
. ,
.
- -. , .
, -
, , ,
. ,
. ,
, . ,
.
, , . ,
. , ,
.

16

:
.

, .

, ,
. , .
,
, : , . , .
.
, . , *. ('
).
, , , .

. , , , , . , ,
. ,

, .
*
, ;
. () ,
. . .

17


: ,

.
, .
, , , ()
.
, :
, .


. ,
,
.
.
:
, . , . 79,
, .
, ,
( !), , .
: ?
, ?
. ,
.
. , . ,
, ?
, ,
?

18


. , , . . , , .
. .
. ,
,
.

,
2012.

, ,
,

.

!
. ,
, , , , . - . *
. , ,
. ! ,
:
.
*

. . .

22

1.
: .
. ,
. ,
, . , ,
,
.
, .
, .
, ,
, . , ,
.


.
, .
, , , .
13% 1962 34% 2008-1.
,
19802010 :2,56,9% 2. ( ) 19972009
30%3.

- ,

23

I.
( ,
29% 20072010)4.
,
.
. , , .
. , ? .
-
. ! , . ,
2000 Journal of
the American Medical Association, ( )
106. 5. .
7. , 20. ,
(, , ), 80. 2. ,

6.
.
, CDC (. 1.1).
? , .
,
- , .
, ?
, ?

24

1.

. 1.1. 7

, , .
,
, . ? , ?
,
, ?
, , , :
, .


.
,
, .

25

I.
, -
, -
, , .
.
, , , .
.
1. , , ,
.
2. , .
.
3. ,
, , , , , ,
.
4. .
.
: , .


- . , ,

26

1.
. , . , ,
. ,
.
:
(). , , ,
. . , . 80%
, 10% 10% .
.
(), ( ,
,
).


? , . , -,
Eunutria,
.
1. 95% , .
2. 100%- .
3. .
4. :
.

27

I.
? . , .
1. .
2. , , , .
3. .
4. (
!).
, .
.
1. , , .
2. .
3. .
4. .
5.
.
?
. , - ,
, ,
, .
, . ,
.
. .
, , , , . ,
.
, .

28

1.

?
,
.
. ? , :
.
,
, .
.
, .
.
:
, ( ).

,
, .
, , ,
, , .

.

? , , .
, . , ,
12% ( ).
,
, .

29

I.
, . ,
:
, ,
.
( ).
,
.
, , . ,
, .
.
, ,

. , , .
,
, .
, , , . , , . .


, .
.
? ,

30

1.
? C?
, , ?
: ,
, ?
. ! , , , ,
: ; , ,
. , !
, 100%
, , 9598%, .
, , , . ,
,
. ,
, .
, , .
, ,
, .
,
, ?
- 100% , 99%,
.
,
. .
, ,

31

I.
. ,
( ), ( ), .
,
()
, 19781980. ,
, .

, ,
.

?
,
, ,
.

.

. ,
, ,
. (
, ,
.)
350, , . . ,

32

1.
,
, .

: ()

( ),
. , 2005,
, . ,
( ) . ,
,
.
.
, - , .
, Google Facebook,
.
, ,
. ( )
,
.
.
- ,
. ( SAD *),
,
*

Sad , . . .

33

I.
, ,
.
, , , . : ?
,
? ?
( )
, , , .
,
.

2



.

, ,
. , , , .
, .
, ,
. , , .

, , . , ,
, , ,
?

, , . , ,

35

I.
,
.
,

.



, ,
, , .
,
,
, .
, ,
.
/ !.., (
). - , : ?
( )? ?
?
, . ,
,
- . , ,
. , , , . ,

36

2.
,
.
? , .
( )
. ,
. , ,
. ,
, () .
. , ,
.
? , , .
, , ,
, . (
) , . ,
, .
,
,
, : -
. ,
.

, .
-
( ?),

37

I.
. . ,

. .

. , .
, . , , .

.
.
.


, ,
, .
.
? (.)
? (.)
? (.)

38

2.

, ,
, ? ,
. :
,
?

.
, . ,
.
, . , 14
McDonalds ( , , )
(
, )
( ). .
1.
1985 -,
, , , ,
()
12. (
) ,
(Food and Drug Administration, FDA) 20062.
,

39

I.
, 565 .
6. ,
?
4,53,5. ,
, ?
, ,
, ( ,
),
: .
- ,
: ,
. -, , .
, , ,
. - , ,
, .


.

? , ? , , , (

40

2.
) , .
,
(. ).
,
. 1980-

. ,
, .
, , . ,
, , Panax.
, ? ,
? , ? , .
1780- -
, , : ( Panax quinquefolius).
,
. . , 55. 700.
!
,
, , , , .
, , .
,
, , , ,
3. !

41

I.
,
: ,
,
?
, . , ,
: , ,
,
. .
, . , , , - (, , ), ,
, ,
.
, ,
: ( ), , , , , , , . ,

.
(, ,
, , )
, ,
.
, ,
, .

42

2.
. , .
. ,
( )
. 1
, ( ) .
(, , ,
, ..)
2 , , .
, ,

.
?
.

(, , , ), . , , ,
.

, () ().
: () . , .
,
?

43

I.
. , ,
. () . 20% ,
5%.
; . 100% 0%.
, .
, .
, , .
.
, : .
, , ! .
- ,
?
?
, , 1940-
1950- ( 70 !) ,

4.
,
. 1960- 1970-5. 1980-
1990- 6 7
. ,
. ,

44

2.
.

.


.
1985 , . ,
8.
.
, : ,
.
5129.
8, , 49 ( , , ), 12 , .
, ,
, 26 .
. (
1985 56; 2012 83,
.) . 49-
96 0 312 .
,
. .
, ,

45

I.
. 6500, ,
, , Journal of the American
Medical Association, :
10.


, . , ,
. , . ,
(
AB), ,
, , .
, 4,53,5, , , ,
, , , ,
.
, ,
. 18? ,
, .
B - .
, , .
, .
, ,
11.
, .
,

46

2.
. , ,
, , . ,
, - . ,
( ? ?).

4,53,5?
, ,
?


, ,
, . '
, ,
, .
.
,
( , ).
.
(
) ,
, ,
, , , ,

47

I.
,
.
, . , . , . , ,
, ,
.. , ,
?
-.
,
,
, . ,
, ,,
. , .
, ,
. , , ,
. ,
. , , ,

, .
- ,
. !
,
,
, .
, , ,

48

2.
, , .
,
-.
,
, , ,
. ,
.
, ,
. , .
, .

3

,

.

, . ,
: , , .
, , .
,
.
: , , .

. , , .
, , ,

50

3.
, .
, , ,
.
. , ? ,
, , .
. , ,
.
.
: , , .
. , ,
. ,
: , . , ,
. , ,
, , , .
1543
, ,
, . , ,
,
. :
, , .
.
, .
( , )

51

I.
. ,
, . , ,
. ( ,

.)
,
: ,
. ,
. ,
. : , .
, .
? , ,
, ?
- . ,
: . ,
, , .
. ,

. - ,
.
,
. , . ,
, .

. ,
. , , -
. , , ,
.

52

3.
. , - . . ,
, (
). ,
. ,
, .
: ! , ,
. ,
. ,
, .
,
.
,
. ,
,
. ,
, . ,
, .
, , : .

,
, . ,
, .

53

I.
, .
, 1947:
, ,
, *.

! ?
.
.
, , . ,
. ,
- ,
, .
, , . , .
, , ,
.

( )
,
1970-. ,
,
.
, , , , - - .
.
,
*

54

It Could Be aWonderful World. . .

3.
1. , . 20%
(). 5%
. ? .
( . 2).
, , .
, , , . ,
, , ,
, .
, ,
.

, , ,
. , ,
. - , , , . ,
, , ,
.
, ,
-,

.
? , ,
,

55

I.
. . ,
. .
, : . - , .
18392-
, (
) !. .
, .
, ,
, . , 20%-
, . ,
, 3.
1983 , , .
,
4. . . , .
, , ,
.
-!
, . (,

56

3.
- )
, , .
, ,
.
, .
, , .

.
,
.
,

.
. ,
. ,
. -
.
,
Cancer Research,

.
, : . ,
. , .

57

I.
,
.
, ,
. , , . ,

, . ,
, . ,
, . , , -
, ,
. , , ,
.
,
, 5.
, .

. , .
, Cancer Epidemiology, Biomarkers& Prevention.
.
, , , , , .

58

3.
, ,

. ,
: , ! ! .
,
.
, , . , ,
. !
,
. ,
.
, ,
.
.
. (
!)


1980- ,
.

59

I.
( ); ,
( ) .
, -
.
, ,
.
, : , .
, , , . , ,
. , ,
- . .
. .
.
, .
, ?
, ,
. : .
,
. ,
, , .

60

3.
, ,
. , ,
. ,
, .
. -,
,
. -, , ,
( ), . - -,
.
, , .
,
.
,
.

,
,
(),
. ,
, . ,
, .

.
, , ,
. (),
. ,
,

61

I.
. ,
. , -
, .
,
.
: ,
.

. ,
, . , , ,
,
.
,
,
.
,
, ,
,
.
, , , .
,
, , .
,
, ,

.

62

3.
, (, , )
( ),
.
. , ,
!
, , , ,
(?) . , , .
( ) ,
.
.
, ,
. , , ,
. , ,
, -
.
, , ,
, , .
? .
. :
- .
( ). ,

.

63

I.
. ,
, , ,
,
. ,
.
, ,
. , ,
, .
, ,
? ,
-.
. . (, , )
, . ,
, , ' . .
.
,
3,28/,
2,284,27 / 6. ( 1980-)
3,28/ .
4,01
7,08 / ( 5,48),
, , 7,
8, 4,14/. ,
, ,

64

3.
? . ,
3,28 / ,
.
, , ,
( ) .

, ,
(,
). . :
.
,
(2,284,27/), (4,017,08/)
.
, ,
. , 2,28 , 4,01.
.
,
, , ,
, .
:
. , ,
.
,
, , 9.

65

I.
, , , , :
10( II). ,
, .
, , , , ,
, . , , ,
(
). , . , ,
' .
, .
,
, . . ,
. ( , ,
, , : , , .
, .)
, .
.
. , , . .

66

3.

():

, , ,
,
.
.
, .
,
, . ,
, : .

II

I,
. :
.
4 ' , .
, , , .
512 , . , , ,
.

,
. , ,
: , . , ,

,
, .
,
- .
,
, ,
.

4

,
, , .
*

? .
: , , , , , .
, :
, , , , ... ,
, .
, . ,

60 . , .
-, . , , ,
, . ,
60. , .
, , ,
.
. 6 60.
,
*

. . .

71

II.
, , , , ,
.
: . , ,
,
, .


2005
, .
, .
: ! ?
, , : ,
?1
3 ,

. , , :
, ,
.
, ,
. .
: .
, , .
: ,

. ,

72

4.
- , , - .
,
, , ,
, . ,
: , ,
, . ,
, , , .
: .


, , ,
. ,
. . ,
, .
, ,
? . , , ,
, .
5, .
, .
: .
. , , .

73

II.

, , .
. ,
, . ,

, , ,
. , ,
, , , -
.
, ,
, ,
.


.
? ?
? ?
.
. ,
.
, . - .
, , .
-, , , ,
,

74

4.
. ( )
, , , , , , , .
- ( ,
) ,
. '
, .
. , ,
(, , ),
. .
- ?
XIII .
. ,
, .
(14731543) , ,
, . (15641642)
.
(16001900) ,
, .
.

,
. , : ,
, ,

75

II.
. , . ,
.
.
: , , (
, ),
( - )
( ).

?
, , .
. ,
: ,
, , , .
,
. -
,
, ?
,
, ? .
,
1931 ,

76

4.
. ,
, , . ,
. , ,
, , , .
. .
,
, , ,
,
. , , , .
. * ,
, ,
.
(, )
. , ,
.


.
. ,
*
(19011976) -,
. . .

77

II.
,
.
, ,
, (14521519).
.

( , ), . : (,
, ) (, , - ).
, !
,
. , ,
.
, , .
.
, , ,
, . ,
, . , ,
, .
, .
,
.

, , ,
.

78

4.
.
, , , . , , - ,
, ,
.


,
, ,
, . ,
. ( .) ,
, ,
, ,
(
). ,
, . , ,
, ,
.
:
, .
. :
, . ,
, , ,
. , ,
, .

79

II.
, ,
, .

. , :
, , , ..
.

, , ,
. ,
,
, , . , ,
.


, , -
.
,
. , , . , , .
,
.
, , . , , , 20
, .

80

4.
95% ,
, , .
, :
.
,
, . ,
, , , , . .
, , ,
? ,
; , , .
, .
,
. ( , )
. . , ,
. ,
,
.

,
, , ,
.

, , ,
.
, . , , , ,
, . , , ,
, . . .
,
. ,
,
. ? . , , .

82

5.
,
. ,
.
. ,
, .
, ,
, ,
.
, ,
, .
.
. ,
: , , , . ,
. ,
.
?
,
,
? FDA , , ,
?
,
,
. , ,
. ,
, .

83

II.


.

, , .
,
.
, -
: , , ( )
, ,

( ).
. : ,
. ,
! , .
, .
:
. . . ?
, .
, , - , .
- : . ,
. .
,
.

84

5.
, ,
, . , ,
, , , - ,
.

, () ,
.
. ,
.
, ,


.
, , (, ) ,
, , , .
.
. , : , , ,
.
, .
,
, ,
.

85

II.
.
,
,
. , ,
, : - ,
1, ,
.
(),
( , , ,
, ). .5.1 , ( 20%-
).
()

()

()

()


()

. 5.1.

86

5.

. , (
), (
, ),
( ),
(
, ).
.
, ,
2. ! , ,
!
-, , .
, .
: , , ,
, , . (
) , () .
-, ,
. , : , ,
. ,
.
,
, :
( , )
- , , , (, ?).

87

II.
, ,
?
? ?
? ,
, ,
. ,

, . ,
( , , ,
, ).
. , , .
.
. .
, ,
, .
. ,
. ,
, .
, , , ,
-, ( ) (
3).
(, -
, ,
).

88

5.

, . , ,
, 4,
, -
.

:
. -
, : ,
.



, , . ,
.
,
.
, , 2022 (, ).
: ( ) , .
.
. , ,
C, ,
D.
- ,
. -

89

II.
, , ,
, . , . ,
,
, .
, . - , ,
.
, . , ,
(. 5.2).

. 5.2. 4

1990
, FDA -

90

5.
. . ,
, .
, ,
. , ,
, ,
( ,
).
, ,
. , ,
; , ,
.
, , . -, . -, ,
( ) , .
, .
. ,
.
2002
, , (
, ). , -
.
, .

91

II.
,
, ,
, . ,
,
.
, .
,
,
.
2530 ( 2007)5.
. , , , D, ,
.
, XIX , - C,
, ,
.

.
,
, . , - ,
.


, , , , ,

92

5.
, .
. . .
. , , : .
, , .
,
, , . ,
40/40/30 , ,
,
.
, . , 2+ 2= 4. ,
. , ' .

1.
? , , , :
,
, . . , , 100 C,
500, , , ,
.
? . , , ,
, .
!
. ,
, ,

93

II.
. ?
, , , ,

.
.
, .
,
, ,
.
-,
( A), 8.
-,
. 2 . , , , .
3-
9-.
.

. ,
. ,
, , ,
. (
,
, .)

94

5.

2.
, .
. , ,
, . - ( ).
319,
40, . .
, 40 -, ,
, , . -
.
(, ,
) 2,7 46126 .
, . , ,
. , -
4, ,
, 2. , -, , 8.
, : ,
, .

3.
- ! , . 400%, (,
-) 300%.

95

II.
, , 8001200%- .
100200%, .

1020% .

, .
,
A&M,
6.
: E , E C, E A A
D. , , E, ,
, , , . ,
, , .
- , A

.
. ,
. ( ), ,
.
, , ,
, .
, , , , - 7.

96

5.
,
. ,
.

,
. , ,
. 10. C , .


,
.
,
.
.
,

(, ). , ,
. , , ,
. ? ? .
, , , ,
. , . , ,
, , .

97

II.
,
. :
. , ,
.
,
(.5.1). .
.
: 1,12,3
510- ()
.

5.1
8

135145/

1,07

3,55/

1,43

340370/

1,09

2,1-2,55/

1,23

921/

2,33

1124/

2,18

0,60,8/

1,33

6078/

1,30

3065/

2,17

()


A()

98

5.
,
, .


: . .
,
.
. , ? -,
, , , , ,
. ( )
, . , .
, , .
, ,
, , , , ,
, .
:
, . ,
- : ,
, , .
, . 1%
,
, .

99

II.
, , ,
, , , ,
.
, , , , .
, . ,
, , ,
.

, .

.
.

,

. ,
.
, .

, ,

.



5, -
. ,
, .

101

II.
, . (, ), ,
A(, ) ,
.
,
-
. ? , , .
1. .
2. .
3. , .
. , . ,
, .
. ,
, :
, . .
,
.
, , , , , .
, ,
, , , .
:
, .
,

102

6.
, , . , , .

. :
,
- ,
,
, .
.
.
, (
) : , - :
,
, , .
? ,
, .

, , .
- , . ,
, ( ) . ,
. (
, ,
!)
,
. :

103

II.


. , ,
, .
: ,
, , ,
. :
,
:
10, 50 ,
,
!
, , ,
, .
(,
!) ,
.
,
. ,
?
, , . ,
,
.
.
, : ,
. . , , ,
, ,
.
, .

104

6.

.
. ,
.
, ,
, (
). XX ,
, . -
, .
, , ,
.
- !
(, )
- XVII.

, ?
,
. : ? ?
?
, , .
. ,
: . ,

105

II.
. ,
, .

1:
()
, , , :
.
.
,
, - .
.
, -.

.
,
, . , ,
.
,
. , .
, , , ,

106

6.
, .
, ,
, , ,
. ,
- , .
.
, , .
, ,
- . , , ,
, , ,
, .
, ,
- ,

.
.
, . ,
, ,
. . ()
(). . . ,
,
. ,
C.
,
.

107

II.
, , .
,
: , . c ,
, .
, ,
, .

2:

,
: .
. , , ,
, ,
. , , , ,
, . ,
, , -
, ,
.
, *, ,
,
, , . , ,
- .
,
. , ,
*

108

Benyus J. Biomimicry: Innovation Inspired by Nature. William Morrow Paperbacks, 2002.

6.
, , ,
,
. , ,
,
.
, ,
. ,
, .
, , .

3:

.
,
. ,
, , , , pH (,

). ,
.

:

( )
.
,

109

II.
.
() , () .
, (). ()
. ,
.
,
, .
: , , .
, ,

. ,
1,
, .

,
. .
(X) , X Y, Y , X
.
, : , .


. , .

110

6.

, , .

:
-
, -
, , -.
, ..,
.
, . ,
: , ,
.
McDonalds, ,
, , .
- ,
, ,
, .
,
, .
, , , ,
. ,
, . ,
, .
. , .

111

II.
: (), ().
,
. : .
? ?
, , ?
, .
, ,
,
? , - ,
? ,
- ,
? - ,
?
,
, ,
, ?
, .
.
, ,
. , ,
. , , .

,

112

6.
. ,
, ,
:
. ,
, . ,
, . , ,

. ,

. , ,
, ,
, .
, , , . , . ,
. , , .
.
, ? 11, ,
. , , ,
. ,
, .
;
.

113

II.



, , ,
. ,
, ,
.
:
,
. , ,
.
, , . ,
, , -
. , ,
.
, .




, , , . ,
: ,

114

6.
.
,
?
. :
,
,
. , , .
,
. ;
, .

-
, .
.

. ,
.


, .
, .
..

, , .
.
: ,
(), 1. , , , ,
,

.

:
,

116

7.
1965 2.
, , Aspergillus flavus3, 4.
.
.
, , .
,
,
,
c5.
- , Aspergillus flavus.
, .
,
,
. USAID*.

, . , , .
, ,
. : .

,
*
United States Agency for International Development
. . .

117

II.
. ,
.
, . - ?
, ,
? ,
,
?
. ,
( !), .
, ,
. 29, , 500 (/) 6,
8600/7. ,
FDA
30/ ( , ,
)8.

, FDA .
. ,
, . ,
. , ,
.
, , , , .
, , 2

118

7.
;
9.
, , ,
. ,
,
, , ,
.
,
,
, ,

10.

, ,
11. ,
, ,
12
13.

,
, , ,
, . , , .
, , , ,
14, -,

119

II.
, .
:
, , ?15
, , ,
16.
,
, , . (
), ;
.
,
, , , 17. ,
18. , .
1968 ,
3. :
19. !
?
, .
,
.
:
,
, , .

120

7.
.
?
,
, . ?
? ,
? ?
,
,
,
, , , .
,
: .

,
.
, ,
.
-, , -

.


, , , .
, ,
. ,
, ,

121

II.

. , .
, .
,
.
, , , . , ,
(),
. , ,
. ,
. , .
, .

.
. ,
,
.
, 19601970- .
,
( ),
.
, ? , ,
. ,
, .

122

7.
, , : -
, .
,
. , - ,
.
, , ,
, .
- . ,
, , , ,
(. 7.1).

. 7.1.

123

II.

reductio ad absurdum, . ,
? (. 7.2).

. 7.2.

, , . , (. 7.3).
.7.2
.
, : , ,

124

7.
, .
.
, .
-
.
,
.7.17.3.

. 7.3.

,
.
, , , .

125

II.
, ,
, .
, , - .



.
, , - .
, , . ,
,
,
. .
,
(, ), , (,
, )
, .
:
(),
(). , , ; .
,
. , ( ),
. ,

, .

126

7.
.
1020. ,
. . .7.4 , .
: , ( ) ( ).
1, 2 .
1
()

()

()

()

. 7.4.

( ) (
). ,
, ( ).
, . ,
, , ,
.
,
, .
, ,
,
(. 7.5).

127

II.

. 7.5. -- (CD38)


. ,
, . -
,
. New World
Encyclopedia (http://www.newworldencyclopedia.org):

,
. ,
. 150
,
: 1012
, 1026, ...

128

7.


,
[]
20.
, ( ) .

. , .
,
, .
. ,
,
, . ,
,
,
.


.
, : ,
.
.
, , ,
, ,

129

II.
, ' .
,
, , . ( ) (, , ),
(, ,
) ( -
),
, , ,
. ,
.
, (
) , .
(. 7.6).
-

. 7.6.

. -, , 1968
(20% ) , -
21, ,
, 22.
,
.
, , ,

130

7.
23. , ,
(,
AFB1). , 24, -
.
: , , ,
. ?
, .
, , ,
,
.
1970-, ,
,
: 25. , : , .
,
.
. , , ,
, ,
, ,
.

131

II.
,
, . 7.7.
-

. 7.7. .

,
, . ,
, ,
, .
, . , ,
. ,
26. , , , , .
,
, .
( ) (. 7.8).
, , . ? :
, ,
?
- . ,
,
, -

132

7.
. , , .
,
.
: ,
. ,
, ,
, , , .
, ,
.
-

+



,
,

. 7.8.

, , . , ,
.
. ,

133

II.
. . , . ,
.
.


, ,
, ,
, . (),
()
( ), ,
,
- . .
,
. -, . ; .

,
27, , 28.
.

' ,
, .
-, ,
,
.

134

7.
, ,
, , . , , , ,
29. , 30.
.
-, . , ,
.
, ,
, .
.

:


( , pH ), .
.

,
. ,
.
. ,
.
.

135

II.
, ,
.
, .
:
, . , ,
. 100.,
, , . , , ,
, . , .
, ,
.
, ,
, .
. ,
,
.

8

( 1)
.
,
.

, .


.
,
: ,
.
, - ,
: , .
.
, , ,

137

II.
. : . ! ,
( ), , :
!
40! , , ,
.
, . , ,
, ,
.


,
: . ,
, .
,
, XX . 1900 , ,
,

-
.
. , ?
, ,

138

8. ( 1)
, , .

:
, , . ,
.
, . , .
XX ,
1,

. , ,
,
,
, .
- ,
, , ,
, , , ,
.
() . ,
, 52
, 1977 *. , ,
,
.
*

Fixx J. The Complete Book of Running. Random House, 1977.

139

II.
, .
, , .
. , .
,
. ,
, , ,
, . : ! ! , .


,
. ,
. , , , 1950- ( )
. , .

. , ? .
:
, . ,
. , 7 2012
New York Times, ,
2.
,

140

8. ( 1)
,
. ,
- Complete
Genomics ( ):
, .
, , , 3.
- . . , ,
. , ,
, , ,
.
, . ,
, , .
, ,
.


, ,
. , , ,
. .
, , ,
, ( ).
,
. , ,

141

II.
103, . , . : ,
, ( ), , , , , . , ! ,

, .


, , ,
, , .

(. 8.1).

. 8.1.

142

8. ( 1)
, .
: (A), (T), (G) (C).
.
; .
,
, - . ,
, 4.
23 , 100
( , ).
.
( 3) ( 25.).
100
.
,
(), , (. 8.2).

:
. 25. , 25. .
, . , ,
,
.
,
.

143

II.

:
( A, T, G C)

:
( A, U, G C)

( 20
)

(
)
:
;


(
)

. 8.2. (, )

.
, .

. ,
. 3
.

, , . , ,
.
.
, . , ,

144

8. ( 1)
,
. ,
, .
.
,
, , ,
, . .
, .
, 7
( ). ,
. ,
.
- , . : ,
.
, .
, 5.
. , , ,
, , , , ...
, .


,
.

145

II.
. ,
,
, -, , . . ,
, , 6,
. ,
, ,
, , .
, . 1990 2003 2025.
,

7.
. , .
,
,
8.
9.
, ,
,
10.

11.

146

8. ( 1)

,

,
. ,
, .
,
. , .
; ,
:
! , . ,
. . ,
, .
,
, ,
.
:
.
. , .
,
.
90% , ,

147

II.
. ,
.
, .
.
, , . . ,
,
.


1955 .
.
.
.
,
( ), .

. , ,
, .
1900- 1950- . XX
-, , *,
. , - ,
.
, . 1912
*

148

. . .

8. ( 1)
, , .
1920- 1930- , AK. ,
, . ,
, . 1948
, B12.
,
, . ,
( ), . , ,
, .

, 1956 . . , ,
A( !).
, - ,
! !
(, .)
, .
, ,
, ,
, .
,
.

149

II.
,
,
?.

, ,
.

?
.
?
, , ?
, ,
tabula rasa ,
. , .
, , .
. , .
, ,
.
,
19801982

, 12
. , , ,
, , ,
.

150

8. ( 1)

.
,
, ,
13, ,
35% .
, ,
30%,
. , .
.
,
, . , , ,
' , . ,

. , ,
90% ( ),
30% ( ), 15%?
, , 135% .
( ),
. ,
, 14, : 35%
. ,
1070%. 35%
, 1070%

151

II.
.
.
, . , , , .
,
. -
.
, . . ,
Washington Nationals .
5:2, 79%.
,
65%. ( , ), ,
, 97%, . ,
, , . ,
, , .
, ,
, .
,
, ,
, .
,
. ,
, . , , .

152

8. ( 1)
? , ? ,
, , ,
.
.

()
()
,
, . , ?
, .
, , , ,
.
.
,
.
, , .
,
.
. 8.3.
, .
:

153

II.
, .8.4. , ,
.

. 8.3. .
,
-

. 8.4. . , .
,

154

8. ( 1)
, ,
, .

*,
. : , . ,
, -,
.
, .
, , , .
(, ) (, ).
,
,
. ,
. ,
, . ,
, . .

,
, .
*
( )
, , ,
.
, ,
, , , . . .

9

( 2)
,
,
.

. . , ,
, , ,
, .
(
). , , .
, .
,
, .


8, . ,
, . , , .

156

9. ( 2)
,
. , , , ;
, .
.
. ,
,
. , , . ( )
- , . ,
.
.
,
(, , ).
.
? . :
. , - .
, , , . , -
.
, .
( ,
, .) .

.

157

II.
,
.
,
,
. .
.
, . ,
,
. . ,
,
.
, , , :
,
. , ,
, , .
, , , .
, -
. ,
. ,
, , ,
.

158

9. ( 2)


, -
, , -
, - ,
, . ,

-. ,
, , ,
. , . *, .
. ,
, (. 9.1).

. 9.1. .
( )

. . . .

159

II.
, , , .
, ,

, B
, . ,
.
(. 9.2).

. 9.2. .
.


,
, 1. ,
4050 , , , , .
, 8090%, ,

160

9. ( 2)
9798% , . , , ,
.
, 100%- .
(
.)
. ,
.

, , .
, ,
,
.


, , , . ,
: , ,
. , , ,
,
. ,
,
.

161

II.

:
(, ).
8, .
. -, .
( ),
- ,
, .
-, ,
.
-
.
, , : , ,
, New York Times ?,
,
. , ,
, , ,
2.
. ,
. .
. . , ,
(, , ) . , , ( , 2000)
( 80.) .

162

9. ( 2)
, ,
, , , , .
!,
.
*
, .
, (, ),
( ).
.
, . : , .
, 1960-

, 3.

,
, .
, .
1950-
*
(Erin Brockovich) ,
, 2000;
(A Civil Action) ,
,
, 1998 .
. . .

163

II.
.
-
, , ,
.
, .
,
, ,
, ,
, .


1958 ,
. ,
,
. ()
: , , .
,
, , , , . , , ,
,
.

164

9. ( 2)


( ).
, . (
)
. , ,
, , , (-), (, ), ( -),
( ), (, )
, , .
, .
( ).
,
,
. ,
.
, , . -,
, ,
. ,
, , , ,
.
. ,
, ,
, , ,
.
,

165

II.
? , ,
1200 .
? , . , ' ,
.
-, , (, ) (): . .
( !):
, .
, . ,
,
.
1980 Federation
Proceedings
, , , ,
. ,
, . 192 . 76 ,
37 (49%) . :
,
? ,
, ,
, .
, , : ,

166

9. ( 2)
, . , . .
,
, , .
, , , , , ,
,
. ,
. ,
!


,
. ,
- .
:
.
, ,
, , ,
: . , , ,
. .
, ,
,
.
,
, .

167

II.
,
. , , , , , .


1980- 1990- , : !
! ,
, , , ,
.
1980-,
()
, .

. ,

.
. . , ,
, . , , ,
.

.

168

9. ( 2)
Federation Proceedings 1980,
: ,
.

, 19421979, (
,
,

).

: ,

. ,
( 1% ),

.

, ,
. . ,
, ,
.
, ,
,
. ,
, .

169

II.
. ,
.
-, ,
, , ,
, .
, ,
.
-, ,
.
, .
. . ,
.
, ,
, - .
-, , . 75.
(
)
. , , ,
.
, (
- ), . ,
, . , ,
, ,
. , ,

170

9. ( 2)

. , , :
, .
, , , ,
. (
), . ,
, : .


, , , -
. , , .

.

,
,
. 2008 ,
:
,
4.
5.
,
-
.

171

II.
, (
): .
, , !
, .

10

,
, ,
*.

,
, , .

, , . , , ,
, , .

' .
, - ,
.
, , , , .
*
, .
. .

173

II.
, ,
: .


4 . ,
.
?
, . . : ,
, , , . , ,
, , . ,
. .
, ,, .
, ,
.
, .
: .
, ,
, .
, . ,
,
, .

174

10.
, ,
. :
, , , ,
.
-
,
, , , . ,
.
: , ,
, .
, .

, -
, .
, -
. . , .
, - .
, , . , .
:
, - . ,

175

II.
. ,
.
, .
, ,
, .
, ,
. , ,
. , , ,
. -.

,

.
, .
, .
, - ,
:
, .
.
: , . ?
, . , . ?
. , ,
? ( 89,
,
, .)

176

10.
? ,
. . .
, ? , , , .
, ,
? .

,

, : .
. ,
(), , , .
, . . ?

, .
, ,
.
, . , , , ,
. (
:
1,
.) .

177

II.
, , , . , ,
, .


. ()
, . , .
, ,
.
. -, , ,
, - , .
, , , . ,
, .
, 2. , ,

( ), , ,
3. . ' , .
,
,
.

178

10.
. ,
( ),

,
, .
. 7,
, .
, ,
, .
,
, , . ,
.
. , ,
, ,
.
,
, . !


,
, , .
, ,
.

179

II.
, .
? ?
?
1662,
, 4. 81 .
. ,

, ,
-10.
. ,
. 8000 , 81, ?
,
. , ,
XIX: .

(- ). , ,
, , (!), , . : ?
, . ?
. , . ,
. ,
.

180

10.

, . , - . , ,
: .
, ,
. ,
- ,
. ? ,
.

, .
: , ,
.
, ,
.
, . ,
( ),
, (
).

. ,
. ,
: , , .
,

181

II.
,
,
, .
, ,
, , . , ,

.

:

,
.
,
, . ,
, . ,
,
: , , , . ,
.
,
, .
, ,
, ,

182

10.
.
, ,
.

,
.
, ,
, , ,
.
, .
, ,

(.10.1).

10.1


()

()

, . ,

183

II.
. ,
, , ,
. ,
; ,
,
.
,
, .

.
, , , .
.
.

11

, :
,
, , , ,
-3 . . 2008

187 1. 68% , 52%
, 2.
.
, , , ,
. 10,
.
,
.

185

II.
, ,
, .
, ,
.
, ,
, .
: . C. ,
, .
, . ,
; ,
, , .


. :
. . . ? ,
, C, K, B6, ,
. AE, ,
, , , 3.
, ?

. , , 1980- ( )

186

11.
.
, ( ),
. ,
, .

, , .
( ).
.
,
. .
,
,
.
,
, .
,
. , / . ,
: ,
, .
, ,
(
95% ).
-,
, ,
.

187

II.
C . , 100 ,
1500 C( , ). , 100,
5,7 C: 1500,
.
263 , ! ,
C, 1% .
. 99 C
,
, .
, 6, . , , .
C,
, C. ( ), ,
.

Nature4 . :
, [C]. ! (
C) .

,

188

11.
. , C,
, .
,
.
( )
, , 5. : , , , .
.
, , .
, .
: C,
, ,
.
(
), ( -
) ( ,
, - ). , ,
.
, , , 6. ,
C , .
C , , ,
C:

189

II.
. 6 (
) , ,
. ,
C( )
.
C . , .
,
, , , , .
, ,
, ,
(
). , ,
. : C ?
: ,
?
, ,
. ,
. - , , .
, .

, .
-.
- .
, .

190

11.



,
, , .
, ,
, , , ,
.
,
,
.
, , .
, , ,
.
. , , : ,
, .
, , ,
. . ,
,
. . , ,
,
.
. .

(

191

II.
), , ,
. - 7, 8 9, , .
,
, .
: E, -
-3.

E
E 192210. ,
, . , E,
. E (), ,
,
11.
E
- 12- , , ,
.
E .
- . -, E,
, ,
. ,
,
.
. , E, , , -

192

11.
()13. ,
14 15.
E
1993 ,
16. E , , ,
, E
( ), ,
, E[ . ..]
. ,
, , , . ,
, E .
, ,
E . ,
. ,
E - 17, 18, 19, 20 21. . ,
( ), : E ,
. , E ,
.
, . 70 ,
300. , , E

193

II.
( A-, )
22. :
E , .
E . 23 ,
, .
,
.
, E(). : , ,
, ,
24. ,
.
, ,
, 25.
,
2627.
:
E, . ,
, .

-3
E, -3(
-3) .

194

11.
; ,
.
-3: - (), () (),
,
-3 -6 .
,
, .
, -3 - . ,
-3 ,
28, 29
( )30, .
-3 .
, , ,
, , , . ( ,
-3, ,
, .) , ,
.

, , , . WebMD
.
-3
. , .

195

II.
89 ( !), , -3 [
. .] ,
- 31.
200.
32, -3( ,
)
. 10.
, -3
. , .
-3
? , , , -3
? ? , .
, . ,
.
. ,
, .

-
, , -: A, . -
,
, , . 1970-

196

11.
, - 33, , ,
, . - (, )
34. , - , ,
.
, -
46%35:
. , 26% -
36. , . ! -
, , .
,
-
. . -
, .
37.
: -
- 38.


, , -, E
,

197

II.
, (, )
. -, E-3,
, , , .
!
, ,
, .
39. ,

, . , ,
, , ,
: . ,
( ,
),
.
E, -
.
40.
,
.
, , , , .
, . -

198

11.
, ,
, .
.
1980-, ,

: , ,
. , , . ,
, :
. , (
), ,
.
, , , .
. ,
,
, . ,
, ,
, ,
.
,
.
, .
, - , ?

199

II.
* .
, .

,
,

.

*
,
(
). . .

12


, ,
.

, . . , ,
, ,
, .
,

,
, ,
.
, , ,
. , , ,
.

201

II.

, ,


,
. . ,
.
, ,
. , 100%. ,
.
: ,
. . , ,
- ,
. -, . ,
, - , , , ,
.
.
, . : (, ) ,
, , , .
, ,
, , ,
.

202

12.
, : ,
, .
, , ,
, .
, : , ,
. , : , , ,
.

, . , 550
,
( , ). , ,
.
1.
1. 8 .
2. 5
( ),
.
3. 100.
. , 900,
500.
4. 2 200 , 80%
, , .

203

II.
.
. ,
, , . , ,
, .
, . :
,
*. , , : (
)
: . ,
.


. , ,

, .

** .
,
*
Hicks J. M. Healthy Eating, Healthy World: Unleashing the Power of Plant-Based Nutrition. BenBella
Books, 2011.
** : . . .
. .: , 2007. ..

204

12.
, , .
ClimateCrisis.net , , 10%, 544
. ,
4900. , ,
:
.
-
, . ,
?!
2006 , 3. ,

.
, ,
18% ,
4. ,
.
18% ,
.
, .
,
, , , , 51% .
, , , .

205

II.
. ,
, .
25 , CO2. ,
,
, , .
.

.
, ,
, 72 , CO25. . ,
, , . ,
.
, . ,
.
? ,
? ,
, 6.



2012 . ,
, , ,
, , ,

206

12.
. ,

(, 100. ),
( ,
).
, ( ,
, , , , , ), .
1020 7,
, .
, ,
. 90% , ,
20% ,
8.
,
. . , 1950--
9% . ,
, . 9.
. , 10. ,
11.
, , ,
.

207

II.

,


.
,
.

, , 1,
. , ,
,
,
, ,
.
: , , .
.
, , , . ,

(Concentrated Animal Feeding Operation, CAFO)
.
. , ,
, . ,
1960-

208

12.
, CAFO.
, ,
, .
, . ,
. .
, , .
. , , . ' - , , . CAFO
- , .
, ,
.
-: ,
.
, 30
, , .
( ), , , ,
.

, , .
, , .
, , ,
. !
, . , . . ,

209

II.
,
. , ,
.
. , .
:
, , . ,
!
, , .

. , ,
. , ,
-
. ,
CAFO ,
, .
, ,
, XXI.

.

, ,
, ,
.

, .

210

12.
-- , , , ,
. , ,
.
, ,
, , .

. , ,
- :
, . -
90% . , , ,
80% . ,
.
, .
, -
.
,
. ,
.
,
, ,
. , , :

211

II.
, . .
,
. Facebook.
,
. .
.

. ,
,
, , , .
.


. . , .
, , . ,
,
, . ,

.
12
. -
. , ,
,
,
.

212

12.
. ,
. ,
, .
, -.
, ,
, : , .

.
,
,
.
,
, . , , - .
,
, .
, .
, ,
.

III

II ,
, , . , . , .
, ,
: . , ,
. ( ,
),
. ? ,
, , .
.
,
. : ,
,
. ,
. ,

. , ,
. ,
. ,

.

13

:
, , ,
, . . , , (, ,
), .
, . , -.
, , .
,
, .

, .
. ,
, 7090%.
, .
,
.

217

III.
, .

.
, ,
.
,
,
, .
, , ,
. , ,
. ,
, . , ,
.
, , , , , . , ,
,
- .
, . .
, , ,
. . ,
, ,
.
. , , . -

218

13.
.
, .
. ,
. , ,
, .
,
. , , ,
,
,
. ,
. , , .
. , .


, , , , , . , : ,
,
.. , , .
,
. .
,
. ,
, , .

219

III.
, , ,
, . .13.1 .

(13.1)


)
(

. 13.1.

220

13.
,
, .
: , .
,
, ,
. ,
,
. , .
, .
. , , ,
, . , :
.
, , , . ,
,
. ,
, .
.
' , . , , ,
, .

221

III.


,
(. 13.2).
, .

(13.2)


(
)

(
)

. 13.2.

222

13.
,
, .
, .
,
,
' , , .
,
,
,
.
.
,
, .
, - ?
,
? ,
,
,
.
, .
, , : . , ,
, , .

. ,
,
. ,

223

III.
, . : (
)
, .
.
(, ) , .
,

. -,
, , ,
,
.

. ,
, . , , , , , . ,
, ,

, .
,
. - , ,
. .

224

13.
,
?
. : . , ,
, (
) ,
- .
, , , , ,
. , ,
, ,
.


. ,
.
.
:
, . ,
. , , ,
. . . , ,
. . .
. , .
.

225

III.
, , .
.
.
( ) ,
, ,
, . , ,
. -,
, .
, ,
. . , ,
,
, .
. ,
. , , , ,
. , , .
.
, ,
,
. ,
.

226

13.


, ?.
, , ?
, ?
.
?
,
.
, .
, , .
(.13.3).

. 13.3.

, , , , . ,
:
. ,
.

227

III.

.

, .
? -3.
, . ? . . ?
. ,
.
, .
;
.
.
.
- , .
: .
, , ,
.
. , ,
, . , . ,
- , , , , .
, ,
, .
( ,

228

13.
, ), .
, ' .
, .


, ,
,
:
, , . , ,
, , .
- , . , ; ,
. ,
, .
, , .
, , , :
. ,
, ,
, . :
, .
-,
. , ,
.

229

III.
, ,

.
,
. , ,
: . ,
.
, , .
?
, ,

. , : . , .
,

. , .
,
, . ,
, , , ,
.
, ,
.

. (
), ( ).

230

13.
, , .
, . ,

, .
: ( ),
( )
, (
). , ,,
, , , .
, - : ?
.
,
, .
, , , .
, . , , , , ,
, , , .
,
, , . .
, ,
. ,

231

III.
. ,
,

. .
, ,
. , ,
. , , , .
, .
,
, , .
, .
, ,
. , , ,
,
. (,
) , .
( ),
, . ,
.

14
:

, , ( ) . ,
, .
.
,
,
, .
, ,
. ,
. ,
.


. , . , . ,
, , . ,
,
,
, ,
.

233

III.
.
, ,
,
. . , , , ,
, .
, ,
,
, .
, .
, , ,
Apple, , .
: .

, .

, ,
, , . ,
,
. , (
: ,
, ). , : ,
.
, , , :
,

234

14. :
. ,
, . , ,
.
, , , , : , , . ,
,
.
, . , , . : ,
?
,

. 2005 .
, , .
: . ,
. . ? ,
.
. , :
.
, . ,
,
, . ,

235

III.
. , , . . , ,
, . ,
.
,
. , ,
: .
,
, , , , . :
.
.
, , . ,
( , ). .

19951
, .

.
,
.
,
,
. , (, , 2)

236

14. :
.
, III IV.

. ,

,
. , ,
.
,
. ,
II III 3.
,
( ), II III. ,
, ,
,
. : . ,

- ,
,
.
, ,
, .
, 146 . , ,
:

4. !

237

III.
. 146,
, .

.
, .
,
20%5, 80% . 38
.
. , , . , ,
: ,
! ( ),
.
, . ,
, , .
, , , ,
:
.
. ,
, .
, ,
. ,
, .
, . ,
, .

238

14. :
. ,
, .
, :
?
: .
,
. :
, !
, .
, ,
. , , . ,
.
, , . ,
. ,
.
,
. ,
, 23.6. ,
. . :
- ? ,
? , - , : .
, ,
.
, ,

239

III.
.
,
. , . .
. ,
,
.
.
, -,
:
, .
,
,
, , , . ,
. . . , , , ,
. . ,
,
, ?
-, : , ,
. , ,
( ),
. .
, . ( ,
,
, 16.)

240

14. :
-, -, . ,
.
,
. , .
-
, .
, , , ,
. - , , , ,
. ,
!
, ,
. .
, .
. ,
. -

, .
, , , ,
. .


,
, , ,

241

III.
, , . ,
,
. ,
.
, .
, ,
, , .
.
? , ?
,
, ?
, .
! , .
, ,
, ,
,
.
? ,
,
,
. -
,
, ? , , ,
. ,
, ,
. ,
, .

242

14. :
, , . ,
. !
( - ,
)7.
- .

, .
1,32
. , , , , 85%
. , ,
1,32 , []
.
, .
, , . :
, , -
.

, : . ,

98 (21333

243

III.
), - . , ,
, . ,
,
, 84% .
,
, . -,
1,32 , 22%
( , ) ,
. -,
, , , ,
FDA, .

, , .
-, ,

, FDA.
! , ,
, . , , 8.
,
( ),
70 , 1,32. , 0,02 1,3 . ,

244

14. :
,
, .
.
1969 , : , ,
.
,
, .
( ),
, 9.

.
.
2008, 2004
61. .
, , , . 2004, , , 371. ,
, .
10.
, ,
, . . ,
, . , -
, , 192 82[ ]
15 20
FDA. , 57,8% ,

245

III.
48,2% 11.
, ,
. 2008 ,
12. ! : , , ,
.
2010 289 13,
80%
14. , , ! . ,
, .
. , . ,
. .
.
, , , ,
.
-
()15.
,
, , 16.
[] - ,
17. !
,

246

14. :
18. . , ,
.
,
. ,

19.
, : : ,
,
20. ,
. . ,
, ,
21. 2:

, .
, , , , .
22, , 31, .
,
( ,
), (
) : , . ,
,

247

III.
, .
? - ,
?
, ,
.
( )
(
?) ( , , )
.
, , .

.

, .


( ,
)
( , 60 ).
. , ,
, , , . I,
:
, .

248

14. :
. ,
: , , ,
, .

, ,
.
, - ,
.
. -
, .
1930- . 1970- 1980-
, . -, 1976


,
23( ,
150% ).
-, 1982
, , 24,
. ,
, ,
, ,
.
, ,
. , ,
!

249

III.
. ,
, , . !
: FDA .

.
.
, .
, .
, . -
, .
() , ,
.
,
,
, .
: , .
,
,
.
, , 1994 , .
, .

250

14. :

, .
, , ,
, .
200825, :
(A, B, C, D, E) , , -3 .

,
II.
,
. 68% , 52%
26. 2007
2530 ,
7,4. 60 . 2007 187 . ,
,
.


, ,
,
. ,
, . , . ,

251

III.
(
), ,
, .

.
, ,
,
, .
. . ,
,
. ,
, , . .

15

,
.

: ?
, ,
? . , ,
: , , , .
,
,
.
, . ,
. ,
.
. -,
, . -,
, . -,
, , , , ,

253

III.
, . , ,
.
, , .
, , ,
.
, , .
, , . ,
, , ,
, , , , .




. , ,
.
,
.
, .
. , ,
, .
. ,
. ,

254

15.
.
, ,
.
. ,
. :
, .

,
, .
. , .

, .
.
, , , , . , ,
,
,
,
. .
.
,
, ,
. ,
. , ,
, .
, ,
, , ,

255

III.
. . ,
. , ,
. , , ,
, , .
, . : .
, : .
-
.

, ?
, ,
? , , 1,

- , .
, '
,
. , ,
. , , , ,

256

15.
,
, .
, ,
,
( , ). ,
,
.
, ,
(, ).
,
.
, , , .
, , , ( ),
.
,
.
:
( ) .


, ,
, ,
.

257

III.
, , ,
, ,
- , . .
: ? ( ) . (, , ,
!)
, . ?
,
. ,
.
,
, . ,
.
, . ,
,
.
, .
. ,
, .
, .
, ,

258

15.

- . , ,
.


,
, . ,
, .
, 2005
Nature, 3000 , , , 15% ,
2.
, : 9,5% ,
20,6%. , .
, , , .
, , ,
.
,
. -, 15,3% :
, , .
, , !
- ,

259

III.
, . -, 12,5% ,

.
, , ,
,
. :
,
, ,
, , , .
, , . -,
.

. -,
. -, 42% .
, 58% ,
, -
.
,
,
, , ,
, ,
.


, , , .

260

15.
,
. , , . , 11,
, , 263 , C.
: ?

. ,
, . ,

.
. ,
, , , .
- ,
,
.
,
. C, . ,
, , .
.
. ,
. ,
.
,
. , .
, ,

261

III.
.
, ,
.
, .
,
. , , .
.
.
.
.

,
, . ,
,
. , : , ,
. , ,

.
.
, .
, . , , , .

262

15.
, , .
.
,
, .
, , , , , , .
. , , ,
, .
(
)
. (, )
: , ; ; , ;
, .
,
. , : , , , , , ..
,
.
, - .

, , .
, . , -
.. (

263

III.
) , .
,

, , .
, , ,
.
, ,
, .
.
, .
. - . ,
, ,
.
. , , .
. ,
. ,
, .
, ,
,
.
,
.
- ,
, .

264

15.
, , , , .
?
' .
- - , ,
,
. -

. , .

, , , . , ,
.
, ,
. , .
, , , ! , ,
, , ,
.
. :
, ,
.
. , ,

265

III.
,
.


,
,
, . , . , ,
, .
, .
,
, ,
. .
,

, ,
?
.
. ? , ,
? :
, .
, ( !).
,
. , ,

266

15.
. 28,
, , , ,
. ! (,
,
.) ,
( 23%
, ,
),
, ,
, . (
,
!
.) , ,
,
.

:

, ,
, ,
, , .
,
, ,
.

267

III.

. , () ,
. , - .
.
,
( ), ( )
. ,

, ,
, . .
, ,

. . ,

.
,
. ,
.
,
3.

. ,
, ,
.

268

15.
, . , ,
.
. 1970- 1980-
( ).
,
, .

. ,
. .
, : ,
.
, , .
, . , ,
.
, ,
!

:

. ,

269

III.
,
.
II, .
, ,
.
.

- .
, .
, , ,
, ( )
, , ,
, . ,

,
. . , - , ,
, .
- , , . , ,
.
E, 11, .
E
4.
. ,

270

15.
E ,
5.
, .
, E,
: 6.
E, , .
, .
( !),
,
, , . ,
. - , .
, .
, ,
?
, . , ,
. ,
, .

16

. ,
,
, , ,
.
.
.

,
.
, ,
.
.
, .
, .
(
).
,
, . ,

272

16.
, .
, , . ,
, Journal of the American Medical Association (JAMA),
, (Public
Broadcasting Service, PBS). ,
:
. , .

. , :
, ,
, .



.
. Nature, JAMA New England
Journal of Medicine (NEJM) ,
.
. Cancer
Research, American Journal of Cardiology ,
.
,
.

. ,
(
), .

273

III.
. .
.
, , ,
, .
, , ,
, (,
) ,
. ,
, .

, ,
. . :
,
.
, , , , .
,
, .
, . , ,
. ,
NEJM, , 2001
380 .
. ,
, .

: . ,

274

16.
,
,
, ,
( ).
, British Medical Journal 80%1. 20102
, . , ,
,
. ?
3.
,
, , , , , .
,
,
?
Whole Foods . Wall Street Journal 2009 , *
: 4.
,
, , ,
.
, - , ,
,
*
Chief Executive Officer ,
. ..

275

III.
, ,
.

. ,
(
).
3 ,
Cancer Research
.
- . , ' ,
. , , ,
,
.
,
.
.
, ,
. ,
. ,
Cancer Research .

True North Health Center
. 5. 176, ,

276

16.

.
,
, . . , JAMA
NEJM,
, , .
.
6, ,
,
, .
JAMA 2007,
. : ,
, ,
10% . , 12
29% .
,
, ,
,
, , .
- . ?
:

. ,
,
.

277

III.
.
. . ,
. .
,
7, ,
,
.


. , , . ,
, , .
( ),
,
, .
, ,
, .
, , ?
, ,
. . ,
( ), ,
( ).
,
,

278

16.
, ,
: !,
!,
? ,
.
,
, ,
. ,
, ,
, .
, , , ,
, ,
. , .
,
, . ,

.
, . , .
, A.
,
, , .
,
.
(-, !) ( ,
).

279

III.
, . ,
,
.
, ,
.
. .
.
. ,
, .

,

.

.
, , . -
, , ,
, . - ,
-. , ,
. ,
.
. ,
, .

280

16.
, , - ,
. ,
, .

,
PBS
2007 , PBS NewsHour . - (American Cancer Society, ACS), 2004
, ,
, 8,
2003.
, , ,
- .
ACS.
: , . ,
, ,
ACS.

9.
,
[ ]
10. , , , .

281

III.
' , .
, . .
200 , 2003, 2004 : 0,5%11.
, .
, , , , , , NewsHour,

, .
, 20022003
0,07%: , .
, ACS,

. , .
!
' , . , , 1%, .
, ,
.
- . ,

ACS, ,
.
. ,
, .

282

16.
, , ,
.
ACS, ,
, , : - . , , . .

- ,
.
,
(, ,
: 2012 5,9 12), .
.
. , , , ,
. , , ,
, .
,
- ACS , ,
. ? ? ? ,
( ) ?
( :
?)
NewsHour ? ?
? ,

283

III.
, ,

, , -.


,
Newsweek. ,
. , , .
, ,
(?),
.
, .
.
Newsweek, .
, . !
.
20 . ,
.
, . , ,
, :
. Newsweek
. ,
,
.

284

16.
,
:

Newsweek
, . ,
,
(
), ,
XXI.
,
Johnson & Johnson. , ,
.
Johnson & Johnson, ,
Newsweek . ,
, ,
? , -
Johnson & Johnson , , . (, : Newsweek
20072009 38%, 2010
1 ,
47 13.)
Newsweek , PBS NewsHour. . , , , ,

285

III.
. , ,
.
: . ? . , PBS, .
, - NewsHour ,
. ,
,
?
, NewsHour.
John S. and James L. Knight
Foundation. , , PepsiCo14. Knight Foundation
1988 Wakefield
Group15, , 16. IV,
2006, Summit Group:
, ApoCell, ,
, Aurora
Diagnostics, 17, ,
, .
18.
Knight Foundation .
NewsHour

286

16.
. ,
. ,
,
.
, ,
. ,
, .
, NewsHour,
, PBS
. 1992,
, New York Times, USA Today Saturday Evening Post
, PBS
: , .
,
PBS (), .
, ,
,
.
, , ,


,
(,
).
, , .

287

III.
.
, ,
.
. , -
. ,
. , ,
. , PBS
.
,
. , ,
, , , .
, PBS, ,
, ? 1992
PBS NewsHour Archer Daniels Midlands
(ADM) , 2011 70 ,
. ,
, PBS . , . 19.
PBS ,
,
.
PBS , .
, PBS .
,
!

288

16.
,
- , , . . , PBS,
, .


.
, Newsweek PBS
. , * . ,
. ,
. , ,
, .
. , ,
, , . : , , , .
, , .
, ,
. .

*
(. 1970) , , ,
, . . .

17

,
.

, , , :
. , .
, ,
, , . , .
.
- , ,
,
,
, .
, : ,
.

290

17.
, ,
,
? . , ,

,
.



,
. OpenSecrets.org, , ( , ,
, , ),
20112012
( 19 ).
( 15 ),
( 9 )1.
,
.
, , ,
, .
2009
, 2.

. .
,
. ,

291

III.

. -
,
. , -
, ,
.
,
. , , .

, , . 2009

3. , Sanofi
4.
, ,
.
2010 ,
(Center for Disease Control
and Prevention, CDC) 20022009, Merck Vaccines5.
, .
. ,
CDC
( *
*
(Chicken Little) 2005,
, ( ).
. .

292

17.
, ) .
. ,
,
Merck. 6, ,
, . ,
,

,
.
.
. ,
, .
, . , ,
-, .
.
,
, , , .
.
, . , , ,
.

293

III.

, . , ,
, .
,
, , . .
, .
, ,
. , , ,
.
,

. , .
, . , , ,
.

, ,
: 2009 2,5 -
7.
. , -
( ) ,

294

17.
,
:
.
, , , .
:
? , , . .
, , 1990- ().
,
.
, .
, ,
:
,
. .
, ,
.
,
.
: , .
,
.
.
, , , ,

295

III.
.
.
General Motors , 1500
, , 8. ,
, .



5 ,
, .
9.
, , ,
, . 5,
.
,
.
,
.
, , ,
,
. ,

: ,
.

296

17.
, , . , .
(). ,
, ( )

. , , (, 98%) .
.
, , ,
( ),
, 98% . ,
,
. ,
, , , , ..
.

,
. - , ,
?
(12001300 )
, (400600 ),
10.
, , , ( )

297

III.
11. (B2) , 1950-
, 12. ( ,
.)
, 300
. ,
. !
.
, !
, . 1011%
, (
). ,
1718% ( ). 2002 , , 35%
13.
! , ( )
(
) .
. , .

,
.

298

17.
, , , ,
14.
, 1982
, , ,
: , ? 30% ( 3537%),
, ?
.
20% ( , ).
, , .
30%
. ,
. 30%
.
, , .
,
, .
, .
1,
.
, 15
,
. ,
.

299

III.
,
, , . ,
?
Journal of the American Medical Association16. ,
, 1999
.
.
, , . ,

, .
, , , 20002002
575. 17.
, . ,
. ,

?
, . - ,

, .


, , , .

300

17.
,
. 28
6882% . ,
. ,

, , ! , , .
, , ,
, ,
.
. .
, .
, ,
, . ,
,
,
, .
,
,
.

.
. ,

301

III.
.
,

. ,

, , .
.
,
. ,
,
.
-
.
, ,
. ,
,

.
, . , : ,
. , , : .
, , 23%
, ' . (, ) 18.

302

17.

, '
.
, , .
, .
2012, , ( FDA, )
, . :

[

]
, ,
.




, .
,

19.
:
, , !

303

III.
( -
):

[]

,
,
, .
, (), ,

55%-
. ,
,
- .
,
,

20.
: , .
. ,

- .
? -, , . ,
, , *.
*
, .
. .

304

17.
,
.
-, , . ,
. ,
. , ,
, .
:
, , :

,

, p53,
,
.
,
21.
: ,
, ,
, ,
, , , , -
.
, ,
!

305

III.
,
. ,
, . ,
( ).
. , ,
.

,
.
. , ,
,
. (
), :
,
, 22.
.
, ,
, , .
-
,
,
( , ,
).

306

17.
( ) . : . , ,
. :
, .
, .
.
,
. ,
, , , , , , .

, , ,
?

18


,
,

. , , , ,
: (ACS),
(MS Society) .
,
(American Society for Nutrition, ASN)
(Academy of Nutrition and Dietetics, AND, 2012 ),

, . ,
,
.
,
,
. ,
.
ACS MSSociety
. MSSociety
, ,

308

18.
, ,
, ,
1. ,
, ,
. .
, , , . ASN, ,

, 2.
,
. ,
,

.
, , .
.
, , , .
, ,
, . ,
,
. . ,
,

,
.

309

III.


, ,
, .
, ,
,
.
.
, .
, , . , , ,

.
, ,

,
.
: ,
.


(ACS) .
,
,
. ACS

310

18.
.
? ,
, . ACS . ACS, ,
2011
: 3
,
.
, , ACS
, .
, , ,
?
.
: , , ,
. ( , -
.) ,
. ACS, ,

,
. AstraZeneca*,
* AstraZeneca - ,
. 1912. . .

311

III.
ACS, , , Amgen ,
, , ACS.
AstraZeneca Amgen Excalibur Donor,
100.
, : Bristol-Myers
Squibb, GlaxoSmithKline, Merck Novartis, Genentech4.

ACS ,
ACS (

?) ,
.
, , ACS. , ACS
, DuPont,
,
. ACS ,
. ACS , ,
. 2009
,
,
5. ACS .

312

18.
ACS
. . Excalibur Donors
Wendys, McDonalds, Unilever/Best Foods (
, Rama, Bertolli,
Hellmanns, Knorr Ben&Jerrys), Coca-Cola.
ACS ,
. , ? ACS
( 6)
. .
1. ,
.
2. .
3. , , .
4. , , ,
.
5. (, )
, .
6. , .
.
() . , , - . (
!

313

III.
! , , 1922,
, - -.)
, .
: , ACS
, . . 2008, ACS
,
, 7.
ACS ,
.
.
(

8)
, ,
. ( , , ACS ,
:
? ? ?)
ACS , . 1980- .
, 1982
, , .

314

18.
(American Institute for Cancer Research, AICR).
1986,
19901997. AICR . , ,
,
,
. . ACS
AICR. , AICR , ACS .
.
!
AICR (ACS
), ACS , . ( ,
, AICR.) ,
ACS,
. ,
- .
, .
, ACS
2003

( -). , .
ACS. ,

315

III.
,
.
.
, , .
,
. , ,
, , .
,
.
, ACS , ,
,
. ACS
, .
, ,


.



,


.
ACS,
.
4%
2011, 165 9,

316

18.
, ,
: , ,
, , .
, Bike
MS, Pure Protein : , , ,
,
, , ,
. Novartis,
.
,
,
, , .
Golden Corral. Sara Lee * 2011
111. Summer Bun. Bimbo Bakeries USA (, ) 2012 ,
,
, : Stroehmann, Freihofers Arnold.
:
, , 10. ( ),
,
*
Sara Lee , ,
. 1939,
2012. . .

317

III.

.
.
,
, , ,
,
(5% 80%)11.
.
:


.

.

,
12.

( ) ( ), .
. ,
. ,
,
,

.

318

18.


ACS MS Society, AND (2012
) , . -
: , , , , , ,
. ,
. - ,
, AND
.
AND ( , ,
) ,
. 201113,
Aramark, The Coca-Cola Company, Hershey Center for Health& Nutrition
National Dairy Council. - Abbott Nutrition, CoroWise
( Cargill ), General Mills, Kellogg, Mars,
McNeil Nutritionals, PepsiCo, Soyjoy, Truvia (
Cargill Coca-Cola), Unilever. 10.
,
, Mars, PepsiCo Coca-Cola.

AND , .
AND
.
: (

319

III.
)
, ()
.
AND . , , , . AND

(Commission on Dietetic
Registration, CDR). ,

AND , CDR
, ,
.
AND
.
*. 1993 ,

. ,
, ,
, . ,
, , ,
,
** 14.
*

Popper P. A. Solving Americas Healthcare Crisis. Bristol Woods Publishing, 2011.

** , ,
. . .

320

18.
, , .
,
.
, ,
AND .
15.
, , AND,
(.18.1).

?


 ,


. 18.1.

: .
. (.18.2)

321

III.
: . !
.
?









10

. 18.2.

, , AND . ,
, , AND. ?
(.18.3).
,
.
. ! , AND AND,
16.

322

18.



,


 !
 !

. 18.3.

AND
, ,
. , , AND,
, ,
17.
AND . ? , . ,
:
Abbott Labs, Aramark, Sodexo Sysco, ,
Coca-Cola,
ConAgra, General

323

III.
Mills Bell, Kraft Foods Global, Nestl' HealthCare Nutrition, PepsiCo
Nutrition US Foods18.
, AND,
CDR :
65. ;
[ ] CDR, , , ;
CDR;
19.
!
,
-, . AND
, , .
, :
, - , ,
.
AND () . 2011 62.
, . Coca-Cola, Pepsi
! AND
- -

324

18.
. , .
, ,
AND
, .
. ,
, , , ,
.


, ASN ( ), ,
, , . ,
,
.
, , , - .
. ASN
( ) ,
.
2025. . ,
. ,
, ,

325

III.
,
.
, : , ,
.
, 15005000,
( 4050. ) , ASN .
,
, ,
, , ,
.
, .
, ,

, General Mills Company
:
. ,
:
, AICR, , 1982
,
, .
6:0( ) .

. , !

326

18.
(
),
, .
, ,
,
. ,
.


, ? .
, , , , ,
. , , (
?). ,
. , ,
,
, ,
,
,
. -
ASN
.
-,
. :
, . ,
,

327

III.
*, , , , , ,
, , . , ,
, .
, , ,
,

. , AstraZeneca Merck,
,

.
,
,
, ,
. ACS -,

,
. ACS ! NewsHour .

. ,
: ,
. -
.
AstraZeneca ,
, ,
(, ).
ACS, .
*

. . .

328

18.
,
, , .

, , , ,
, ,
, ,
, , , .


, ,
. .
, , , , ,
. ,
, , ,
,
, .
, , , ,
. ,
, , ,
, .
, ,
. 3 2012
ACS , ACS,

329

III.

, 20.
: , ,
. :

,
, : ? ,
...
, ,
, ,
, .
, , . . ,
, . .
, ,
,
.
,
, , ,

. . .
, .
, , .
.
, ,
, ,

330

18.
. .
, , ,
, ,
. .
: .
ACS, , AND ASN ,
, , .
,
, , , . ,
, .

IV

19



,
,
,
, ,
.
Mat Factor Caf
, -

, , .
, .
, .
, ,

, ,
.
. . , ,
. ,

334

19.
, . .
,
, . .
. , .
,
,
. , , , ,
. , ,
. ,
, ,
.
. , ,
. ,

, .
, . ,
, . ,
.
, , ,
( )
( ) . ,

, .

335

IV.
,
, ,
, ,
. , ,
. , ,
, , .
, ,
- ,
. , , , : .
,
, .
,
. ,
.

. , , , .
, ,
- , .
,
, ,
-, ,

336

19.
,
, .
, - (, ), -
, .
, ,
, , ,
. , ,

.

, .
, ,
. ,
, . ,
' .
,
.
,
, .
.
,
,
. ,
, , .
, - , .

337

IV.
, ,
,
.
,
, .

, , ,
: , .
, -,
.
,
. , ,
-,
. , ,
,
, , , . .
.
, , , . -
, , ,
.
, .
?
, .
, ,

338

19.
, ( , ). ,
. ,
, , .
, , , , , . ,
, , ,
.
, ,
, ,
- . .
: , , ,
. (
*. ,
, , : , .)
, .
.
. ,
, .
.

.

*
: . .
. .: , , 2013. ..



.
. , , ,
, .
.
,
, , ' . .
, . . , BenBella,
.
.
.
, , .
, .
: , ,
, .
, ,
, .
.

340


, , ,
( ,
),

.
, ,
.
,
,
. .
.
,
.



, . ,
, ,
, 2005
. , .
,
, .
(tcolincampbell.org) eCornell
.
-
, ,
. , . Google AdWords
*. ,
.
: howard@permanator.com.

*
: . Google AdWords .
: , 2009. . .

342


I
1
1. Hellmich N. U.S. Obesity Rate Leveling Off, at about One-Third of
Adults// USA Today, 2010. January 13// http://www.usatoday.com/
news/health/weightloss/2010-01-13-obesity-rates_N.htm.
2. U.S. Centers for Disease Control and Prevention. Crude and AgeAdjusted Percentage of Civilian, Noninstitutionalized Population with
Diagnosed Diabetes, United States, 19802010. : 21 2012// http://www.cdc.gov/diabetes/statistics/
prev/national/figage.htm.
3. United States Environmental Protection Agency. Cardiovascular Disease
Prevalence and Mortality. : 2011//
http://cfpub.epa.gov/eroe/index.cfm?fuseaction=detail.viewPDF&ch
=49&lShowInd=0&subtop=381&lv=list.listByChapter&r=235292.
4. International Diabetes Federation. Morbidity and Morality. 2009, August
3// http://webcache.googleusercontent.com/search?q=cache:http://
www.idf.org/book/export/html/23040.
5. Starfield B. Is US Health Really the Best in the World?// Journal of the
American Medical Association. 2000. Vol. 284, N. 4. P. 483485.
6. .
7. Centers for Disease Control and Prevention. 10Leading Causes of Death
by Age Group, United States 2010. 2
2012 // http://www.cdc.gov/injury/wisqars/pdf/10LCID_All_
Deaths_By_Age_Group_2010-a.pdf.

343

2
1. Vogel R. A., Corretti M. C., Plotnick G. D. Effect of aSingle High-Fat
Meal on Endothelial Function in Healthy Subjects// American Journal
of Cardiology. 1997, February 1. Vol. 79, N. 3. P. 350354.
2. Hitti M. FDA Approves New Angina Drug: Ranexa Is for Patients Who
Havent Responded to Other Chest Pain Drugs // WebMD. 2006.
February 7// http://www.webmd.com/heart-disease/news/20060207/
fda-approves-new-angina-drug.
3. Waters J. The History of American Ginseng. 10
2012// http://www.telliquah.com/Ginseng/Ginseng.htm.
4. Morrison L. M. Arteriosclerosis: Recent Advances in the Dietary and
Medicinal Treatment// Journal of the American Medical Association.
1951. Vol. 145, N. 16. P. 12321236; Morrison L. M. Diet in Coronary
Atherosclerosis// Journal of the American Medical Association. 1960.
Vol. 173, N. 8. P. 884888.
5. Pritikin N., McGrady P. M. The Pritikin Program for Diet and Exercise.
Bantam Books, 1984. P. 438.
6. Esselstyn C. B. Jr. Prevent and Reverse Heart Disease: The Revolutionary,
Scientifically Proven, Nutrition-Based Cure. New York: Avery Trade,
2008; Esselstyn C. B. Jr., Ellis S. G., Medendorp S. V., Crowe T. D.
AStrategy to Arrest and Reverse Coronary Artery Disease: A5-Year
Longitudinal Study of aSingle Physicians Practice// Journal of Family
Practice, 1995. Vol. 41, N. 6. P. 560568.
7. Ornish D. Eat More, Weigh Less. New York: HarperCollins, 1993; Ornish
D., Brown S. E., Scherwitz L. W. et al. Can Lifestyle Changes Reverse
Coronary Heart Disease?// Lancet. 1990. Vol. 336, No. 8708. P. 129133.
8. Esselstyn et al. AStrategy to Arrest and Reverse.
9. Esselstyn C. B. Jr. Updating a 12-year Experience with Arrest and
Reversal Therapy for Coronary Heart Disease (An Overdue Requiem for
Palliative Cardiology)// American Journal of Cardiology. 1999. Vol. 84.
P. 339341.

344


10. Hitti M. FDA Approves New Angina Drug: Ranexa Is for Patients Who
Havent Responded to Other Chest Pain Drugs // WebMD. 2006
February 7// http://www.webmd.com/heart-disease/news/20060207/
fda-approves-new-angina-drug.
11.
. ,
, .

3
1. Madhavan T. V., Gopalan C. The Effect of Dietary Protein on Carcinogenesis
of Aflatoxin // Archives of Pathology. 1968, February. Vol. 85, N. 2.
P.133137.
2. Mulder G. J. On the Composition of Some Animal Substances// Journal
fu
r praktische Chemie, 1839. Vol. 16. P. 129152(,
, Munro H. N. Mammalian protein metabolism.
Vol. I/ H. N. Munro and J. B. Allison (eds.). Academic Press, 1964.
P.129). Mulder G. J. The Chemistry of Vegetable & Animal Physiology,
trans. P. F. H. Fromberg, W. Blackwood & Sons. Edinburgh, Scotland,
1849.
3. Schulsinger D. A., Root M. M., Campbell T. C. Effect of Dietary Protein
Quality on Development of Aflatoxin B1-Induced Hepatic Preneoplastic
Lesions // Journal of the National Cancer Institute, 1989. Vol. 81.
P.12411245.
4. Youngman L. D. Recall, Memory, Persistence, and the Sequential
Modulation of Preneoplastic Lesion Development by Dietary Protein.
Cornell University, 1987. Masters Thesis (T. C. Campbell, Mentor).
5. Dunaif G. E., Campbell T. C. Relative Contribution of Dietary Protein
Level and Aflatoxin B1Dose in Generation of Presumptive Preneoplastic
Foci in Rat Liver// Journal of the National Cancer Institute, 1987. Vol.78.

345


P. 365369; Youngman L. D., Campbell T. C. Inhibition of Aflatoxin
B1-Induced Gamma-Glutamyl Transpeptidase Positive (GGT+) Hepatic
Preneoplastic Foci and Tumors by Low Protein Diets: Evidence That
Altered GGT+ Foci Indicate Neoplastic Potential// Carcinogenesis,
1992. Vol. 13, N. 9. P. 16071613.
6. Chen J., Campbell T. C., Li J., Peto R. Diet, Life-Style and Mortality
in China. Astudy of the characteristics of 65Chinese counties. Oxford,
United Kingdom; Ithaca, NY; and Beijing, Peoples Republic of China:
Oxford University Press, Cornell University Press, and Peoples Medical
Publishing House, 1990.
7. Muldoon M. F., Manuck S. B., Matthews K. A. Lowering Cholesterol
Concentrations and Mortality: A Quantitative Review of Primary
Prevention Trials// BMJ, 1990. Vol. 301, N. 6747. P. 309314.
8. Stemmermann G. N., Nomura A. M., Heilbrun L. K. et al. Serum Choles
terol and Colon Cancer Incidence in Hawaiian Japanese Men// Journal of
the National Cancer Institute, 1981. Vol. 67, N. 6. P. 11791182.
9. Madhavan T. V., Gopalan C. The Effect of Dietary Protein on Carcino
genesis of Aflatoxin// Archives of Pathology, 1968, February. Vol. 85,
N. 2. P. 133137.
10. Madhavan T. V., Gopalan C. Effect of Dietary Protein on Aflatoxin Liver
Injury in Weanling Rats// Archives of Pathology, 1965, August. Vol. 80.
P. 123126.

II
4
1. Wallace D. F. David Foster Wallace, In His Own Words// More Intelligent
Life, September 19, 2008// http://moreintelligentlife.com/story/davidfoster-wallace-in-his-own-words.

346

5
1. , 1956

.
- , !
2. Preston R. S., Hayes J. R., Campbell T. C. The Effect of Protein Deficiency
on the In Vivo Binding of Aflatoxin B1to Rat Liver Macromolecules//
Life Sciences, 1976, October 15. Vol. 19, N. 8. P. 11911198.
3. Mainigi K. D., Campbell T. C. Subcellular Distribution and Covalent
Binding of Aflatoxins as Functions of Dietary Manipulation// Journal of
Toxicology and Environmental Health, 1980. Vol. 6. P. 659671.
4. MonaVie: Discover the Beat of aHealthy Heart http://www.acaiberry.
com/monavie-pulse/.
5. Office of Dietary Supplements. Dietary Supplement Fact Sheet:
Multivitamin/mineral Supplements// http://ods.od.nih.gov/factsheets/
MVMS-HealthProfessional.
6. Kubena K. S., McMurray D. N. Nutrition and the Immune System:
AReview of Nutrient-Nutrient Interactions// Journal of the American
Dietetic Association, 1996. Vol. 96. P. 11561164.
7. Campbell T. C., Hayes J. R. Role of Nutrition in the Drug Metabolizing
System// Pharmacological Reviews, 1974. Vol. 26. P. 171197.
8. Tietz N. W. Textbook of Clinical Chemistry. Philadelphia, PA: W.B.
Saunders Co., 1986.

6
1. , - ,
, . ,
30% , .

347

7
1. Campbell T. C., Hayes J. R. Role of Nutrition in the Drug Metabolizing
Enzyme System// Pharmacological Reviews, 1974, September. Vol. 26,
N. 3. P. 171197; Campbell T. C., Hayes J. R. The Role of Aflatoxin in Its
Toxic Lesion// Toxicology and Applied Pharmacology. 1976, February.
Vol. 35, N. 2. P. 199222.
2.
,
AFB1.
3. Sargeant K., Sheridan A., OKelly J., Carnaghan R. B. A. Toxicity Asso
ciated with Certain Samples of Groundnuts// Nature, 1961. Vol.192.
P. 10961097.
4. Lancaster M. C., Jenkins F. P., Philp J. M. Toxicity Associated with Certain
Samples Of Groundnuts // Nature, 1961. Vol. 192. P. 10951096;
Butler W. H., Barnes J. M. Toxic Effects of Groundnut Meal Containing
Aflatoxin to Rats and Guinea Pigs// British Journal of Cancer, 1964.
Vol.17, N. 4. P. 699710; Wogan G. N., Newberne P. M. Dose-Response
Characteristics of Aflatoxin B1 Carcinogenesis in the Rat // Cancer
Research, 1967, December 27. N. 12. P. 23702376.
5. Lancaster et al. Toxicity; Butler and Barnes. Toxic Effects.
6. Campbell T. C., Caedo J. P. Jr., Bulatao-Jayme J. et al. Aflatoxin M1in
Human Urine// Nature, 1970. Vol. 227. P. 403404.
7. Campbell T. C., Salamat L. A. Aflatoxin Ingestion and Excretion by
Humans// Mycotoxins in Human Health/ I. F. Purchase (ed.). London:
Macmillan, 1971. P. 263269/
8. Campbell T. C. Present Day Knowledge on Aflatoxin// Philippine Journal
of Nutrition, 1967. Vol. 20. P. 193201.
9. . , ,
.
10. , . , ,

348


, ,
.
.
11. Campbell et al. Aflatoxin M1in Human Urine; Campbell T. C., Sinnhuber
R. O., Lee D. J. et al. Brief Communication: Hepatocarcinogenic Material
in Urine Specimens from Humans Consuming Aflatoxin// Journal of the
National Cancer Institute, 1974. Vol. 52. P. 16471649.
12. Campbell et al. Brief Communication.
13. .
.
14. Wogan and Newberne. Dose-Response Characteristics; Portman R.S.,
Plowman K. M., Campbell T. C. On Mechanisms Affecting Species
Susceptibility to Aflatoxin// Biochimica et Biophysica Acta, 1970, June.
Vol. 208, N. 3. P. 487495.
15. Portman et al. On Mechanisms Affecting Species.
16. Allcroft R., Carnaghan R. B. A. Groundnut Toxicity: And Examination
for Toxin in Human Food Products from Animals Fed Toxic Groundnut
Meal// Veterinary Record, 1963. Vol. 75. P. 259263.
17. Conney A. H. Pharmacological Implications of Microsomal Enzyme
Induction// Pharmacological Reviews, 1967. Vol. 19. P. 317366.
18. Maso M. Decrease in Mixed Function Oxidase Activity in Rat Liver
Over Time. Cornell University, 1979. Undergraduate Honors Thesis
(T.C.Campbell, Mentor).
19. Madhavan and Gopalan. Effect of Dietary Protein on Carcinogenesis.
20. Lewis R. L. The Unity of the Sciences. Volume One: Do Proteins Teleport
in an RNA World? New York: International Conference on the Unity of
the Sciences, 2005.
21. Madhavan T. V., Gopalan C. The Effect of Dietary Protein on Carcino
genesis of Aflatoxin// Archives of Pathology, 1968, February. Vol. 85,
N. 2. P. 133137.
22. Madhavan and Gopalan. Effect of Dietary Protein on Aflatoxin; Madhavan
and Gopalan. Effect of Dietary Protein on Carcinogenesis.

349


23. Hayes J. R., Mgbodile M. U. K., Campbell T. C. Effect of Protein Deficiency
on the Inducibility of the Hepatic Microsomal Drug-metabolizing Enzyme
System. I. Effect on Substrate Interaction with Cytochrome P-450//
Biochemical Pharmacology, 1973. Vol. 22. P. 10051014; Mgbodile
M. U. K., Hayes J. R., Campbell T. C. Effect of Protein Deficiency on
the Inducibility of the Hepatic Microsomal Drug-metabolizing Enzyme
System. II. Effect on Enzyme Kinetics and Electron Transport System//
Biochemical Pharmacology, 1973. Vol. 22. P. 11251132; Hayes J. R.,
Campbell T.C. Effect of Protein Deficiency on the Inducibility of the
Hepatic Microsomal Drug-metabolizing Enzyme System. III. Effect of
3-Methylcholanthrene Induction on Activity and Binding Kinetics//
Biochemical Pharmacology, 1974. Vol. 23. P. 17211732.
24. Madhavan and Gopalan. The Effect of Dietary Protein on Carcinogenesis.
25. Garner R. C., Miller E. C., Miller J. A. et al. Formation of aFactor Lethal
for S. Typhimurium TA1530 and TA1531 on Incubation of Aflatoxin
B1with Rat Liver Microsomes// Biochemical and Biophysical Research
Communications, 1971. Vol. 45. P. 774780.
26. Doherty W. P., Campbell T. C. Aflatoxin Inhibition of Rat Liver Mito
chondria// Chemical and Biological Interactions, 1973. Vol. 7. P. 6377.
27. Hayes J. R., Mgbodile M. U. K., Merrill A. H. Jr. et al. The Effect of
Dietary Protein Depletion and Repletion on Rat Hepatic Mixed Function
Oxidase Activities// Journal of Nutrition, 1978. Vol. 108. P. 17881797;
Nerurkar L. S., Hayes J. R., Campbell T. C. The Reconstitution of Hepatic
Microsomal Mixed Function Oxidase Activity with Fractions Derived from
Weanling Rats Fed Different Levels of Protein// Journal of Nutrition,
1978. Vol. 108. P. 678686.
28. Hayes J. R. et al. Effect of Dietary Protein; Nerurkar L. S., Hayes J. R.,
Campbell T. C. The reconstitution of hepatic microsomal mixed function
oxidase activity with fractions derived from weanling rats fed different
levels of protein// Journal of Nutrition, 1978. Vol. 108. P. 678686;
Hayes et al. Effect of Protein Deficiency I.

350


29. Adekunle A. A., Hayes J. R., Campbell T. C. Interrelationships of Dietary
Protein Level, Aflatoxin B1Metabolism, and Hepatic Microsomal Epo
xide Hydrase Activity// Life Sciences, 1977. Vol. 21. P. 17851792.
30. Mainigi K. D., Campbell T. C. Effects of Low Dietary Protein and Dietary
Aflatoxin on Hepatic Glutathione Levels in F-344Rats// Toxicology and
Applied Pharmacology, 1981. Vol. 59. P. 196203.

8
1. ,
, , ,
. : - , ,
, , , .
2. Markoff J. Cost of Gene Sequencing Falls, Raising Hopes for Medical
Advances// New York Times, March 7, 2012// http://www.nytimes.
com/2012/03/08/technology/cost-of-gene-sequencing-falls-raisinghopes-for-medical-advances.html.
3. .
4. ,
(A-T G-). ,
. 16, 64.
. , ,
810 , , , , . .
, : 3 ( ).

351


, 2935 6600 ,
--! , .
3 . ,
, ,
. , ,
.
5. . 95% , ,
.
, , .
6. Gene Therapy. Human Genome Project Information. : 24 2011.
7. ; Lazarou J., Pomeranz B. H., Corey P. N. Incidence of Adverse
Drug Reactions in Hospitalized Patients: AMeta-analysis of Prospective
Studies// Journal of the American Medical Association, 1998. Vol. 279,
N. 15. P. 12001205// . : Pharmacogenomics// Human Genome
Project Information, : 19 2011.
8. Lazarou, Pomeranz and Corey. Incidence of Adverse Drug Reactions.
9. .
10. .
11. ; Pharmacogenomics// Human Genome Project Information.
: 19 2011.
12. Committee on Diet, Nutrition, and Cancer. Washington, DC: National
Academies Press, 1982.
13. Doll R., Peto R. The Causes of Cancer: Quantitative Estimates of
Avoidable Risks of Cancer in the United States Today// Journal of the
National Cancer Institute, 1981. Vol. 66, N. 6. P. 11921265.
14. .

352

9
1. Carroll K. K., Braden L. M., Bell J. A., Kalamegham R. Fat and Cancer//
Suppl., Cancer, 1986. Vol. 58, N. 8. P. 18181825; Drasar B. S.,
Irving D. Environmental Factors and Cancer of the Colon and Breast//
British Journal of Cancer, 1973. Vol. 27, N. 2. P. 167172; Higginson
J. Etiological Factors in Gastrointestinal Cancer in Man// Journal of
the National Cancer Institute, 1966, October. Vol. 37, N. 4. P. 527
545; Higginson J. Present Trends in Cancer Epidemiology// Canadian
Cancer Conference (Honey Harbour, Ontario: Proceedings of the Eighth
Canadian Cancer Conference, 1969). P. 4075; Higginson J., Muir C. S.
Epidemiology in Cancer// Cancer Medicine/ J. F. Holland, E. Frei (eds.).
Philadelphia: Lea and Febiger, 1973. P. 241306; Higginson J., Muir
C. S. Environmental Carcinogenesis: Misconceptions and Limitations
to Cancer Control// Journal of the National Cancer Institute, 1979,
December. Vol. 63, N. 6. P. 12911298; Wynder E. L., Shigematsu T.
Environmental Factors of Cancer of the Colon and Rectum// Cancer,
1967, September. Vol. 20, N. 9. P. 15201561.
2. Tortorello M. Is It Safe to Play Yet? // New York Times, March 14,
2012 // http://www.nytimes.com/2012/03/15/garden/going-toextreme-lengths-to-purge-household-toxins.html.
3. Campbell C., Friedman L. Chemical Assay and Isolation of Chick Edema
Factor in Biological Materials// Journal of the American Association for
Agricultural Chemistry, 1966. Vol. 49. P. 824828.
1980- .
4. Huff J., Jacobson M. F., Davis D. L. The Limits of Two-Year Bioassay
Exposure Regimens for Identifying Chemical Carcinogens// Environ
mental Health Perspectives, 2008. Vol. 116. P. 14391442.
5. Cohen S. M. Risk Assessment in the Genomic Era// Toxicologic Patho
logy, 2004. Vol. 32. P. 38.

353

10
1. Singh Y., Palombo M., Sinko P. J. Recent Trends in Targeted Anticancer
Prodrug and Conjugate Design// Current Medicinal Chemistry, 2008.
Vol. 15, N. 18. P. 18021826; Lu Y. H., Gao X. Q., Wu M. et al. Strategies
on the Development of Small Molecule Anticancer Drugs for Targeted
Therapy// Mini Reviews in Medicinal Chemistry, 2011. Vol.11. P. 611
624; Munagala R., Aqil F., Gupta R. C., Promising Molecular Targeted
Therapies in Breast Cancer// Indian Journal of Pharmacology, 2011.
Vol. 43, N. 3. P. 236245; Panitch H., Applebee A. Treatment of Walking
Impairment in Multiple Sclerosis: An Unmet Need for aDisease-Specific
Disability // Expert Opinion on Pharmacotherapy, 2011, March 12.
N. 10. P. 15111521; Rautio J., Kumpulainen H., Heimbach T. etal.
Prodrugs: Design and Clinical Applications// Nature Reviews: Drug
Discovery, 2008. Vol. 7, N. 3. P. 255270; Ettmayer P., Amidon G. L.,
Clement B., Testa B. Lessons Learned from Marketed and Investigational
Prodrugs// Journal of Medicinal Chemistry, 2004, May. Vol. 47, N. 10.
P. 23932404.
2. - . ,
, .
3. Singh et al. Recent Trends.
4. Internationals Statistical Classification of Diseases and Related Health
Problems// Answers.com. 11 2012//
http://www.answers.com/topic/icd.

11
1. Thurston C. Dietary Supplements: The Latest Trends & Issues //
Neutraceuticals World, 2008, April 1// http://www.nutraceuticalsworld.
com/issues/2008-04/view_features/dietary-supplements-the-latesttrends-amp-issues/.

354


2. Thurston C. Dietary Supplements: The Latest Trends & Issues //
Nutraceuticals World, 2008, April// http://www.nutraceuticalsworld.
com/issues/2008-04/view_features/dietary-supplements-the-latesttrends-amp-issues.
3. Apples, Raw, Skin. Self NutritionData. 11
2012 // http://nutritiondata.self.com/facts/fruits-and-fruitjuices/1809/2.
4. Eberhardt M. V., Lee C. Y., Liu R. H. Antioxidant Activity of Fresh
Apples// Nature, 2000, June 22. Vol. 405, N. 6789. P. 903904.
5. Boyer J., Liu R. H. Review: Apple Phytochemicals and Their Health
Effects// Nutrition Journal, 2004. Vol. 3, N. 5// http://www.nutritionj.
com/content/3/1/5.
6. ; Wolfe K., Wu X. Z., Liu R. H. Antioxidant Activity of Apple
Peels// Journal of Agricultural and Food Chemistry, 2003, January 29.
Vol. 51, N. 3. P. 609614.
7. Morris C. D., Carson S. Routine Vitamin Supplementation to Prevent
Cardiovascular Disease: A Summary of the Evidence for the U.S.
Preventive Services Task Force// Annals of Internal Medicine, 2003.
Vol. 139, N. 1. P. 5670.
8. U.S. Preventive Services Task Force. Routine Vitamin Supplementation
to Prevent Cancer and Cardiovascular Disease: Recommendations and
Rationale// Annals of Internal Medicine, 2003. Vol. 139, N. 1. P. 5155.
9. .
10. Evans H. M., Bishop K. S. On the Existence of aHitherto Unrecognized
Dietary Factor Essential for Reproduction// Science, 1922. Vol. 56,
N.1458. P. 650651.
11. Farbstein D., Kozak-Blickstein A., Levy A. P. Antioxidant Vitamins and
Their Use in Preventing Cardiovascular Disease// Molecules, 2010.
Vol. 15, N. 11. P. 80988110; Aggarwal B. B., Sundarum C., Prasad
S., Kannappan R. Tocotrienols, the Vitamin Eof the 21st Century: Its
Potential against Cancer and Other Chronic Diseases// Biochemical
Pharmacology, 2010. Vol. 80, N. 11. P. 16131631.

355


12. Hennekens C. H., Gaziano J. M., Manson J. E., Buring J. E. Antioxidant
Vitamin-Cardiovascular Disease Hypothesis Is Still Promising, But
Still Unproven: The Need for Randomized Trials// American Journal of
Clinical Nutrition, 1995. Vol. 62. P. 1377S1380S.
13. Pearce B. C., Parker R. A., Deason M. E. et al. Hypercholesterolemic
Activity of Synthetic and Natural Tocotrienols// Journal of Medicinal
Chemistry, 1992. Vol. 35, N. 20. P. 35953606.
14. .
15. Augustyniak A. et al. Natural and Synthetic Antioxidants: An Updated
Overview// Free Radical Research, 2010. Vol. 44, N. 10. P. 12161262.
16. Rimm E. B., Stampfer M. J., Ascherio A. et al. Vitamin EConsumption
and the Risk of Coronary Heart Disease in Men// New England Journal
of Medicine, 1993, May 20. Vol. 328, N. 20. P. 14501456; Stampfer
M. J., Hennekens C. H., Manson J. E. et al. Vitamin EConsumption
and the Risk of Coronary Disease in Women// New England Journal of
Medicine, 1993, May 20. Vol. 328, N. 20. P. 14441449.
17. Sesso et al. Vitamins Eand C; Lee I. M., Cook N. R., Gaziano J. M. et
al. Vitamin Ein the Primary Prevention of Cardiovascular Disease and
Cancer: The Womens Health Study: ARandomized Controlled Trial//
Journal of the American Medical Association, 2005. Vol. 294, N. 1. P.56
65; Lonn E. et al. Effects of Long-Term Vitamin ESupplementation on
Cardiovascular Events and Cancer: ARandomized Controlled Trial//
Journal of the American Medical Association, 2005. Vol. 293, N. 11.
P.13381347; Vivekananthan D. P., Penn M. S., S. K. Sapp et al. Use
of Antioxidant Vitamins for the Prevention of Cardiovascular Disease:
Meta-analysis of Randomised Trials// Lancet, 2003, June 14. Vol. 361,
No. 9374. P. 20172023.
18. Lee et al. Vitamin Ein the Primary Prevention; Lonn et al. Effects of
Long-Term Vitamin E; Kirsh V. A. et al. Supplemental and Dietary
Vitamin E, Beta-Carotene, and Vitamin CIntakes and Prostate Cancer
Risk// Journal of the National Cancer Institute, 2006, February 15.

356


Vol. 98, N. 4. P. 245254; Lippman S. M. et al. Effect of Selenium
and Vitamin E on Risk of Prostate Cancer and Other Cancers: The
Selenium and Vitamin ECancer Prevention Trial (SELECT)// Journal
of the American Medical Association, 2009, January 7. Vol. 301, N. 1.
P. 3951.
19. Lippman et al. Effect of Selenium; Liu S., Lee I. M., Song Y. et al. Vitamin
Eand Risk of Type 2Diabetes in the Womens Health Study Randomized
Controlled Trial// Diabetes, 2006, October. Vol. 55, N. 10. P. 2856
2862.
20. Christen W. G., Glynn R. J., Sesso H. D. et al. Age-Related Cataract
in a Randomized Trial of Vitamins E and C in Men // Archives of
Ophthalmology, 2010, November. Vol. 128, N. 11. P. 13971405.
21. Tsiligianni I. G., van der Molen T. ASystematic Review of the Role of
Vitamin Insufficiencies and Supplementation in COPD// Respiratory
Research, 2010, December 6. Vol. 11. P. 171.
22. Bjelakovic G., Nikolova D., Gluud L. L. et al. Antioxidant Supplements for
Prevention of Mortality in Healthy Participants and Patients with Various
Diseases// Cochrane Database of Systematic Reviews, 2012. Vol. 3.
23. Dotan Y., Lichtenberg D., Pinchuk I. No Evidence Supports Vitamin
EIndiscriminate Supplementation// Biofactors, 2009. Vol. 35, N.6.
P. 469473; Blumberg J., Frei B. Why Clinical Trials of Vitamin Eand
Cardiovascular Diseases May Be Fatally Flawed // Free Radical
Biology& Medicine, 2007. Vol. 43, N. 10. P. 13741376.
24. Aggarwal et al. Tocotrienols.
25. Farbstein et al. Antioxidant Vitamins.
26. Lonn et al. Effects of Long-Term Vitamin E.
27. Bjelakovic et al. Mortality in Randomized Trials; Miller et al. Metaanalysis.
28. Ebbesson S. O. et al. Fatty Acid Consumption and Metabolic Syndrome
Components: The GOCADAN Study// Journal of the Cardiometabolic
Syndrome, 2007. Vol. 2, N. 4. P. 244249.

357


29. Lopez-Garcia E., Schulze M. B., Manson J. E. et al. Consumption of
(n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and
Endothelial Activation in Women// Journal of Nutrition, 2004. Vol. 134,
N. 7. P. 18061811; Deckelbaum R. J., Worgall T. S., Seo T. n-3Fatty
Acids and Gene Expression // Suppl., American Journal of Clinical
Nutrition, 2006. Vol. 83, N. 6. P. 1520S1525S.
30. Kaushik S. V., Mozaffarian D., Spiegelman D. et al. Long-Chain
Omega-3 Fatty Acids, Fish Intake, and the Risk of Type 2 Diabetes
Mellitus// American Journal of Clinical Nutrition, 2009. Vol. 90, N. 3.
P. 613620.
31. Hooper L. et al. Risks and Benefits of Omega 3 Fats for Mortality,
Cardiovascular Disease, and Cancer: Systematic Review// BMJ, 2006.
Vol. 332, N. 7544. P. 752760.
32. Kaushik et al. Long-Chain Omega-3Fatty Acids.
33. Foote C. S., Chang Y. C., Denny R. W. Chemistry of Singlet Oxygen.
X. Carotenoid Quenching Parallels Biological Protection// Journal of
the American Chemical Society, 1970. Vol. 92, N. 17. P. 52165218;
Packer J. E., Mahood J. S., Mora-Arellano V. O. et al. Free Radicals and
Singlet Oxygen Scavengers: Reaction of aPeroxy-radical with -carotene,
Diphenyl Furan and 1,4-diazobicyclo(2,2,2)-octane// Biochemical and
Biophysical Research Communications, 1981. Vol. 98, N. 4. P. 901906.
34. Peto R., Doll R., Buckley J. D. Can Dietary Beta-Carotene Materially
Reduce Human Cancer Rates?// Nature, 1981. Vol. 290, N. 5803. P.
201208.
35. Omenn G. S. Chemoprevention of Lung Cancers: Lessons from CARET,
the Beta-Carotene and Retinol Efficacy Trial, and Prospects for the
Future// European Journal of Cancer Prevention, 2007. Vol. 16, N. 3.
P. 184191.
36. Omenn G. S. et al. Effects of aCombination of Beta Carotene and Vitamin
Aon Lung Cancer and Cardiovascular Disease// New England Journal
of Medicine, 1996. Vol. 334, N. 18. P. 11501155.

358


37. Omenn. Chemoprevention of Lung Cancers.
38. Saremi A., Arora R. Vitamin Eand Cardiovascular Disease// American
Journal of Therapeutics, 2010. Vol. 17, N. 3. P. e56e65; Farbstein etal.
Antioxidant Vitamins.
39. Augustyniak et al. Natural and Synthetic Antioxidants.
40. ; Farbstein et al. Antioxidant Vitamins; Aggarwal et al. Toco
trienols; Dotan et al. No Evidence Supports Vitamin E; Ndhlala A. R.,
Moyo M., Van Staden J. Natural Antioxidants: Fascinating or Mythical
Biomolecules? // Molecules, 2010. Vol. 15, N. 10. P. 69056930;
Becker E. M., Nissen L. R., Skibsted L. H. Antioxidant Evaluation
Protocols: Food Quality or Health Effects// European Food Research
and Technology, 2004. Vol. 219, N. 6. P. 561571.

12
1. Pimentel D. et al. Environmental and Economic Costs of Soil Erosion and
Conservation Benefits// Science, 1995. Vol. 267, N. 5201. P. 1117
1123; Segelken R. in Cornell University news release (Ithaca, NY, 1997);
Pimentel D. in Canadian Society of Animal Science Meetings (Montreal,
1997).
2. Food and Agriculture Organization of the United Nations. Deforestation
Causes Global Warming// News release, September 4, 2006// http://
www.fao.org/newsroom/en/news/2006/1000385/index.html.
3. Steinfeld H., Gerber P., Wassenaar T. et al. Livestocks Long Shadow:
Environmental Issues and Options, Food and Agriculture Organization of
the United Nations: Rome (2006)// ftp://ftp.fao.org/docrep/fao/010/
a0701e/a0701e00.pdf.
4. .
5. Goodland R. Our choices to overcome the climate crisis// NGO Global
Forum 14. Gwangju, Korea, 2011.
6. , . ,

359


, (Whats Your Beef? //
National Trust, 2012// http://animalwelfareapproved.org/2012/05/16/
national-trust-%E2%80%93-%E2%80%98what%E2%80%99s-yourbeef%E2%80%99-report/).
,
.
7. Kromm D. E. Ogallala Aquifer // Water Encyclopedia, 11 2012// http://www.waterencyclopedia.com/
Oc-Po/Ogallala-Aquifer.html; Manjula V. Guru and James E. Horne,
The Ogallala Aquifer. Poteau, Oklahoma: The Kerr Center for Sustainable
Agriculture, 2000// http://www.kerrcenter.com/publications/ogallala_
aquifer.pdf.
8. Manjula V. Guru and James E. Horne, The Ogallala Aquifer.
9. .
10. .
11. .
12. Barnard N. D. Foods That Fight Pain: Revolutionary New Strategies for
Maximum Pain Relief. New York: Three Rivers Press, 1999. P. 368.

III
14
1. Hildenbrand G. L., Hildenbrand L. C., Bradford K., Cavin S. W. Five-Year
Survival Rates of Melanoma Patients Treated by Diet Therapy after the
Manner of Gerson: ARetrospective Review// Alternative Therapies in
Health and Medicine, 1995. Vol. 1, N. 4. P. 2937.
2.
1936
1940-.

360


3. Kavanagh D., Hill A. D., Djikstra B. et al. Adjuvant Therapies in the
Treatment of Stage II and III Malignant Melanoma// Surgeon, 2005.
Vol. 3, N. 4. P. 245256.
4. Dewar D. J., Newell B., Green M. A. et al. The Microanatomic Location
of Metastatic Melanoma in Sentinel Lymph Nodes Predicts Nonsentinel
Lymph Node Involvement// Journal of Clinical Oncology, 2004. Vol. 22,
N. 16. P. 33453349.
5. .
6. . 1
: 500 . ,
50%.
7. Light D. W., Warburton R. N. Extraordinary Claims Require Extraordinary
Evidence// Journal of Health Economics, 2005. Vol. 24. P. 10301033.
8. Light D. W., Warburton R. N. Drug R&D Costs Questioned: Widely
Quoted Average Cost to Bring Drugs to Market Doesnt Appear to Hold
Up to Scrutiny// Genetic Engineering& Biotechnology News, 2011,
July 1. Vol. 31, N. 13// http://www.genengnews.com/gen-articles/
drug-r-d-costs-questioned/3707/.
9. Direct-to-Consumer Advertising// Wikipedia,
16 2012 // http://en.wikipedia.org/wiki/Direct-toconsumer_advertising.
10. Big Pharma Spends More on Advertising Than Research and Develop
ment, Study Finds// ScienceDaily (blog), January 7, 2008// http://
www.sciencedaily.com/releases/2008/01/080105140107.htm.
11. The Mount Sinai Hospital/Mount Sinai School of Medicine. Majority
of Pharmaceutical Ads Do Not Adhere to FDA Guidelines, New Study
Finds// ScienceDaily, August 18, 2011// http://www.sciencedaily.
com/releases/2011/08/110818093052.htm.
12. York University. Big Pharma Spends More on Advertising than Research
and Development, Study Finds // ScienceDaily, January 7, 2008 //
http://www.sciencedaily.com/releases/2008/01/080105140107.htm.

361


13. Pharmaceutical Industry// Wikipedia, 30 2012 // http://en.wikipedia.org/wiki/Pharmaceutical_
Industry.
14. Wikipedia. List by countries by GDP (nominal), 2 2012// http://en.wikipedia.org/wiki/List_of_countries_
by_GDP_(nominal).
15. Yusuf S. Two Decades of Progress in Preventing Vascular Disease//
Lancet, 2002. Vol. 360, N. 9326. P. 23; Wald N. J., Law M. R. AStrategy
to Reduce Cardiovascular Disease by More Than 80%// BMJ, 2003.
Vol. 326, N. 7404. P. 14191424; Lonn E., Bosch J., Teo K. K. et al.
The Polypill in the Prevention of Cardiovascular Diseases: Key Concepts,
Current Status, Challenges, and Future Directions// Circulation, 2010.
Vol. 122, N. 20. P. 20782088.
16. Wald and Law. AStrategy to Reduce.
17. Lonn et al. The Polypill.
18. Wald and Law. AStrategy to Reduce.
19. Combination Pharmacology and Public Health Research Working Group.
Combination Pharmacotherapy for Cardiovascular Disease// Annals of
Internal Medicine, 2005. Vol. 143, N. 8. P. 593599; Wise J. Polypill
Holds Promise for People with Chronic Disease// Bulletin of the World
Health Organization, 2005. Vol. 83, N. 12. P. 885887.
20. Lonn et al. The Polypill.
21. Ebrahim S., Beswick A., Burke M., Davey S. G. Multiple Risk Factor
Interventions for Primary Prevention of Coronary Heart Disease //
Cochrane Database of Systemic Reviews, October 18, 2006: CD001561.
22. Ebrahim et al. Multiple risk factor interventions.
23. Frequently Asked Questions August 2010: CODEX and Dietary Supple
ments// CodexFund.com, 11 2012//
http://www.codexfund.com/faq.htm.
24. Committee on Diet, Nutrition, and Cancer, Diet, Nutrition, and Cancer.
Washington, DC: National Academies Press, 1982.

362


25. Thurston. Dietary Supplements.
26. .
, .
.

15
1. , , ,
.
2. Martinson B. C., Anderson M. S., de Vries R. Scientists Behaving
Badly// Nature, 2005, June 9. Vol. 435. P. 737738.
3.
, .
4. Farbstein et al. Antioxidant Vitamins.
5. Bjelakovic et al. Mortality in Randomized Trials; Miller et al. Metaanalysis; Lonn et al. Effects of Long-Term Vitamin E.
6. Augustyniak et al. Natural and Synthetic Antioxidants; Farbstein et al.
Antioxidant Vitamins; Aggarwal et al., Tocotrienols.

16
1. Smith R. Medical Journals: AGaggle of Golden Geese// BMJ Group
(blog), July 3, 2012// http://blogs.bmj.com/bmj/2012/07/03/richardsmith-medical-journals-a-gaggle-of-golden-geese/.
2. Lundh A., Barbateskovic M., Hrobjartsson A., Gotzsche P. C. Conflicts
of Interest at Medical Journals: The Influence of Industry-Supported
Randomised Trials on Journal Impact Factors and Revenue Cohort
Study// PLoS Medicine, 2010. Vol. 7. P. 17.
3. Handel A. E., Patel S. V., Pakpoor J. et al. High Reprint Orders in Medical
Journals and Pharmaceutical Industry Funding: Case-control Study//

363


British Medical Journal, 2012, June 28. Vol. 344. P. e4214, doi:10.1136/
bmj.e4212.
4. Goldstein J. Whole Foods CEO: We sell a bunch of junk // Wall
Street Journal Health Blog, August 6, 2009// http://blogs.wsj.com/
health/2009/08/05/whole-foods-ceo-we-sell-a-bunch-of-junk/.
5. Goldhamer A., Lisle D. L., Parpia B. et al. Medically Supervised Water-Only
Fasting in the Treatment of Hypertension// Journal of Manipulative and
Physiological Therapeutics, 2001. Vol. 24, N. 5. P. 335339; Goldhamer
A., Lisle D. L., Parpia B. et al. Medically Supervised Water-Only Fasting
in the Treatment of Borderline Hypertension// Journal of Alternative
and Complementary Medicine, 2002, October. Vol. 8, N. 5. P. 643650.
6. Gardner C. D., Kiazand A., Alhassan S. et al. Comparison of the Atkins,
Zone, Ornish, and LEARN diets for Change in Weight and Related Risk
Factors among Overweight Premenopausal Women. The Ato ZWeight
Loss Study: ARandomized Trial// Journal of the American Medical
Association, 2007. Vol. 297, N. 9. P. 969977.
7. Grants/ The Dr. Robert C. and Veronica Atkins Foundation. 1 2012// http://www.atkinsfoundation.org/
grants.asp.
8. Lehrer J. The News Hour with Jim Lehrer. January 20, 2007.
9. Emery C., Rockoff J. Cancer Death Rate Falls // News & Observer
(Raleigh, NC), January 18, 2007, 1A, 14A.
10. Associated Press. Cancer Deaths Drop for 2nd Straight Year// MSNBC.
com, January 17, 2007// http://www.msnbc.msn.com/id/16668688/
ns/health-cancer/t/cancer-deaths-decline-nd-straight-year/.
11. .
12. National Cancer Institute. NCI Budget Requests. 1 2011 // http://www.cancer.gov/aboutnci/
servingpeople/nci-budget-information/requests.
13. Obituary: Sidney Harman, 19182011// BloombergBusinessweek, April
14, 2011// http://www.businessweek.com/magazine/content/11_17/
b4225024048922.htm.

364


14. Alberto Ibargu
en, President and CEO// John S. and James L. Knight
Foundation, 2012// http://www.knightfoundation.org/staff/albertoibarguen/.
15. Anna Spangler Nelson, Trustee // John S. and James L. Knight
Foundation, 2012 // http://www.knightfoundation.org/staff/annaspangler-nelson/.
16. Weisbecker L. Wakefield Group Joins VCs Going Invisible// Triangle
Business Journal, July 6, 2009// http://www.bizjournals.com/triangle/
stories/2009/07/06/story6.html.
17. Services // Aurora Diagnostics, 2011 // http://www.auroradx.com/
hospital-services/.
18. Management// Powell Investment Advisors, 2011.
19. ADM ,
, ( *).

17
1. Top Interest Groups Giving to Members of Congress, 2012Cycle//
OpenSecrets.org, 9 2012// http://www.
opensecrets.org/industries/mems.php.
2. Influence & Lobbying: Health Professionals // OpenSecrets.org,
1 2012// http://www.opensecrets.org/
industries/indus.php?Ind=H01.
3. Elias Zerhouni // Wikipedia, 9
2013// http://en.wikipedia.org/wiki/Elias_Zerhouni.
*
(The Informant)
, 2009 .
,
; , .
. .

365


4. Johns Hopkins Medicine. Former NIH Director Elias Zerhouni Rejoins
Johns Hopkins Medicine as Senior Advisor, 2
2012// http://www.hopkinsmedicine.org/news/media/releases/
Former_Nih_Director_Elias_Zerhouni_Rejoins_Johns_Hopkins_
Medicine_as_Senior_Advisor.
5. Dr. Julie Gerberding Named President of Merck Vaccines //
BusinessWire, December 21, 2009// http://www.businesswire.com/
news/home/20091221005649/en/Dr.-Julie-Gerberding-NamedPresident-Merck-Vaccines.
6. Stone J. Mr. Gates, Dr. Julie Gerberding Told Dr. Sanjay Gupta Vaccines
Cause Autism, Did You Forget?// Age of Autism, February 7, 2011//
http://www.ageofautism.com/2011/02/mr-gates-dr-julie-gerberdingtold-dr-gupta-vaccines-cause-autism-did-you-forget.html.
7. U.S. Census Bureau, Statistical Abstract of the United States. Table
134. National Health Expenditures Summary: 1960to 2009, 1 2009// http://webcache.googleusercontent.
com/search?q=cache:http://www.census.gov/compendia/statab/2012/
tables/12s0134.pdf.
8. Frick A. GM CEO: Serious Health Care Reform Undoubtedly Would
Help Level the Playing Field// Think Progress, December 5, 2008//
http://thinkprogress.org/politics/2008/12/05/33286/gm-health-carereform/?mobile=nc.
9. ,
, . .
10. Hegsted D. M. Calcium and osteoporosis// Journal of Nutrition, 1986.
Vol. 116. P. 23162319.
11. . .
12. Campbell T. C., Brun T., Chen J. et al. Questioning riboflavin recom
mendations on the basis of asurvey in China// American Journal of
Clinical Nutrition, 1990. Vol. 51. P. 436445.

366


13. The National Academies. Report Offers New Eating and Physical
Activity Targets to Reduce Chronic Disease Risk, September 5,
2002 // http://www8.nationalacademies.org/onpinews/newsitem.
aspx?RecordID=10490.
14. . : http://
www.jeffnovick.com/RD/Should_I_Eat_That.html.
15. Starfield B. Is US Health Really the Best in the World?
16. .
17. .
18. . 1989
,
IVAX, -, Celera
Corporation// Ivax and Teva on the Heels of Taxol and Zovirax// The
Pharma Letter, April 7, 1997 // http://www.thepharmaletter.com/
file/41937/ivax-and-teva-on-the-heels-of-taxol-and-zovirax.html;
Samuel Broder// LinkedIn, 1 2012//
http://www.linkedin.com/pub/samuel-broder/25/649/b31.
19. Aflatoxin & Liver Cancer// The National Institute of Environmental
Health Sciences, 9 2007.
20. .
21. .
22. Campbell T. C., Chen J., Liu C. et al. Nonassociation of Aflatoxin
with Primary Liver Cancer in aCross-Sectional Ecological Survey in
the Peoples Republic of China // Cancer Research, 1990. Vol. 50.
P.68826893.

18
1. About the Society// National Multiple Sclerosis Society,
1 2012// http://www.nationalmssociety.org/about-thesociety/index.aspx.

367


2. About the Academy of Nutrition and Dietetics// Academy of Nutrition
and Dietetics, 2012 // http://www.eatright.org/Media/content.
aspx?id=6442467510.
3. Epstein S. S. National Cancer Institute and American Cancer Society:
Criminal Indifference to Cancer Prevention and Conflicts of Interest.
Bloomington, NY: Xlibris, 2011.
4. Cancer Prevention Coalition. The American Cancer Society (ACS) More
Interested in Accumulating Wealth Than Saving Lives, Warns Samuel S.
Epstein, M.D.// PR Newswire, 3 2012//
http://www.prnewswire.com/news-releases/the-american-cancersociety-acs-more-interested-in-accumulating-wealth-than-saving-liveswarns-samuel-s-epstein-md-117942029.html.
5. Screening for Breast Cancer// U.S. Preventive Services Task Force, July
2010// http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm.
6. Diet and Physical Activity: Whats the Cancer Connection?// American
Cancer Society, 13 2012 //
http://www.cancer.org/cancer/cancercauses/dietandphysicalactivity/
diet-and-physical-activity.
7. Dairy Foods & Cancer Prevention// Dairy Council Digest, 2008, January/
February. Vol. 79, N. 1. P. 6// http://www.nationaldairycouncil.org/
SiteCollectionDocuments/health_wellness/dairy_nutrients/dcd791.pdf.
8. Jarvis W. T. Cancer Quackery// National Council Against Health Fraud,
December 17, 2000// http://www.ncahf.org/articles/c-d/caquackery.html.
9. Sources of Support// National Multiple Sclerosis Society,
2 2012// http://www.nationalmssociety.org/about-thesociety/sources-of-support/index.aspx.
10. Women against MS Luncheon: Sponsorship Opportunities// Triangle
WAMS Luncheon website, 1 2012 //
http://www.trianglewams.org/event-details/sponsorship-opportunities.
11. . 34

368


, . 262266. . : Swank R. L.,
Dugan B. B. Effect of Low Saturated Fat Diet in Early and Late Cases of
Multiple Sclerosis// Lancet, 1990. Vol. 336, N. 8706. P. 3739.
12. Nutrition and Diet// National Multiple Sclerosis Society,
1 2012// http://www.nationalmssociety.org/living-withmultiple-sclerosis/healthy-living/nutirtion-and-diet/index.aspx.
13. The Academys Annual Reports// Academy of Nutrition and Dietetics,
2012// http://www.eatright.org/annualreport/.
14. Popper P. Solving Americas Healthcare Crisis. Worthington, OH: Bristol
Woods Publishing, 2011, Kindle edition, Kindle location 4932.
15. , , 15 2012.
16. , AND
Forbes.com: Is the ADA Intentio
nally Using State Legislatures to Block Alternative Nutrition Providers?//
http://www.forbes.com/sites/michaelellsberg/2012/07/10/american_
dietetic_association_2/.
17. , , 16 2012.
18. Commission on Dietetic Registration Continuing Professional Education
Accredited Providers// Commission on Dietetic Registration, Academy
of Nutrition and Dietetics, 1 2012.
19. Benefits of Becoming a CPE Accredited Provider // Commission on
Dietetic Registration, Academy of Nutrition and Dietetics,
1 2012.
20. Lichtenfeld J. L. During Breast Cancer Awareness Month We Must Not
Only Celebrate Our Success But Also Understand Our Limitations//
Dr. Lens Blog, American Cancer Society, October 3, 2012// http://
www.cancer.org/aboutus/drlensblog/post/2012/10/03/during-breastcancer-awareness-month-we-must-not-only-celebrate.



,
: http://www.mann-ivanov-ferber.ru/
: http://blog.mann-ivanov-ferber.ru/
Facebook: http://www.facebook.com/mifbooks
: http://vk.com/mifbooks
: http://www.mann-ivanov-ferber.ru/about/
predlojite-nam-knigu/
: http://www.mann-ivanov-ferber.ru/about/
job/




The China Study
Starting Implication for Diet, Weight Loss
and Long-term Health
Colin Campbell, Thomas Campbell
!
1
1400 mazon.com
10

2005 ,
VegNews

.
, , , .
, . , ,
, , -: ,
- .

, , ,
.

65 ,
- , .
8000 .
, ,
, .
, ,
.

; , , ; 25
(1998 );
.
325 .
, .



The Blue Zones
Lessons for Living Longer From the People Whove Lived the Longest
Dan Buettner

, ? .
. , .
, .
. ,
. ,
.

, .

National Geographic.
ted.com 900 .

.
National Geografic.
- Quest Network,
.
, , ted.com 950 .
.




Drop Dead Healthy
One Mans Humble Quest for Bodily Perfection
A.J. Jacobs

- , ,
, . , ,
, .
Drop Dead Healthy - , . , ,
.
.
.

, .

,
.

, The Know-It-All, The Year of Living Biblically The


Guinea Pig Diary. , Esquire, The New York Times The Washington
Post. www.ajjacobs.com.

, , , ,
. !
, ;
, ,
.
. 12 , , , ,
( ), , , .

, , , ,
.

. . : -
. , , 12 .

-, .




-
,
( LOOI, www.looi.ru)

,